API Technologies (ATNY) 10-Q 8 Apr 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Feb. 28, 2015	Apr. 02, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	28-Feb-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Trading Symbol	ATNY
Entity Registrant Name	API TECHNOLOGIES CORP.
Entity Central Index Key	1081078
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		55,397,384

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Feb. 28, 2015	Nov. 30, 2014
In Thousands, unless otherwise specified
Current
Cash and cash equivalents	$6,199	$8,258
Accounts receivable, less allowance for doubtful accounts of $696 and $716 at February 28, 2015 and November 30, 2014, respectively	35,955	38,657
Inventories, net (note 4)	58,231	54,718
Deferred income taxes	539	561
Prepaid expenses and other current assets	1,535	1,592
Assets, Current, Total	102,459	103,786
Fixed assets, net	29,524	30,574
Goodwill	116,770	116,770
Intangible assets, net	28,071	29,848
Other non-current assets	1,911	1,862
Total assets	278,735	282,840
Current
Accounts payable and accrued expenses	28,635	27,907
Deferred revenue	2,407	2,279
Current portion of long-term debt (note 7)	10,916	10,097
Total current liabilities	41,958	40,283
Deferred income taxes	4,651	4,575
Other long-term liabilities	1,386	1,216
Long-term debt, net of current portion (note 7)	114,865	118,214
Deferred gain (note 7c)	7,639	7,788
Liabilities, Total	170,499	172,076
Commitments and contingencies (note 12)
Shareholders' Equity
Common shares ($0.001 par value, 250,000,000 authorized shares, 55,397,320 and 55,397,320 shares issued and outstanding at February 28, 2015 and November 30, 2014, respectively)	55	55
Special voting stock ($0.01 par value, 1 share authorized, issued and outstanding at February 28, 2015 and November 30, 2014, respectively)	0	0
Additional paid-in capital	327,925	327,846
Common stock subscribed but not issued	2,373	2,373
Accumulated deficit	-222,284	-220,105
Accumulated other comprehensive income	167	595
Stockholders' Equity Attributable to Parent	108,236	110,764
Total Liabilities and Shareholders' Equity	$278,735	$282,840

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Feb. 28, 2015	Nov. 30, 2014
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts	$696	$716
Common shares, par value	$0.00	$0.00
Common shares, shares authorized	250,000,000	250,000,000
Common shares, shares issued	55,397,320	55,397,320
Common shares, shares outstanding	55,397,320	55,397,320
Special voting stock, par value	$0.01	$0.01
Special voting stock, share authorized	1	1
Special voting stock, Share Issued	1	1
Special voting stock, Share Outstanding	1	1

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014
Revenue, net	$50,850	$58,918
Cost of revenues
Cost of revenues	37,859	45,274
Restructuring charges	42	299
Total cost of revenues	37,901	45,573
Gross profit	12,949	13,345
Operating expenses
General and administrative	5,279	5,719
Selling expenses	3,655	3,757
Research and development	2,000	2,074
Business acquisition and related charges	62	110
Restructuring charges	830	118
Total operating expenses	11,826	11,778
Operating income	1,123	1,567
Other expense (income), net
Interest expense, net	3,127	2,410
Amortization of note discounts and deferred financing costs	23	665
Other expense (income), net	-120	110
Nonoperating Income (Expense)	3,030	3,185
Loss before income taxes	-1,907	-1,618
Expense for income taxes	272	506
Net loss	-2,179	-2,124
Accretion on preferred stock		-393
Net loss attributable to common shareholders	-2,179	-2,517
Net loss per share-Basic and diluted	($0.04)	($0.05)
Weighted average shares outstanding
Basic	55,461,217	55,426,635
Diluted	55,461,217	55,426,635
Comprehensive income (loss)
Unrealized foreign currency translation adjustment	-428	141
Other comprehensive income (loss)	-428	141
Comprehensive loss	($2,607)	($1,983)

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Shareholders Equity (USD $)	Total	Common Stock	Additional Paid-in Capital	Common Stock Subscribed But Not Issued	Accumulated Deficit	Accumulated Other Comprehensive Income
In Thousands, except Share data
Balance at Nov. 30, 2014	$110,764	$55	$327,846	$2,373	($220,105)	$595
Balance (in shares) at Nov. 30, 2014		55,397,320
Stock-based compensation expense	79		79
Net loss for the period	-2,179				-2,179
Other comprehensive loss	-428					-428
Balance at Feb. 28, 2015	$108,236	$55	$327,925	$2,373	($222,284)	$167
Balance (in shares) at Feb. 28, 2015		55,397,320

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014
Cash flows from operating activities
Net loss	($2,179)	($2,124)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	3,459	4,130
Amortization of note discounts and deferred financing costs	23	665
Stock based compensation	79	-48
Gain on sale of fixed assets	-149	-99
Deferred income taxes	98	335
Changes in operating asset and liabilities, net of business acquisitions
Accounts receivable	2,410	-2,555
Inventories	-3,830	5,427
Prepaid expenses and other current assets	39	855
Accounts payable and accrued expenses	560	-4,575
Deferred revenue	153	476
Net cash provided by operating activities	663	2,487
Cash flows from investing activities
Purchase of fixed assets	-159	-105
Purchase of intangible assets	-107	-55
Net proceeds from disposal of fixed assets (note 7c)		15,108
Business acquisitions (note 10)		1,414
Net cash provided (used) by investing activities	-266	16,362
Cash flows from financing activities
Repayments of long-term debt (note 7)	-2,500	-25,480
Net proceeds from long-term debt (note 7)		9,508
Net cash used by financing activities	-2,500	-15,972
Effect of exchange rate on cash and cash equivalents	44	54
Net change in cash and cash equivalents	-2,059	2,931
Cash and cash equivalents, beginning of period	8,258	6,351
Cash and cash equivalents, end of period	$6,199	$9,282

NATURE_OF_BUSINESS_AND_BASIS_O

NATURE OF BUSINESS AND BASIS OF PRESENTATION	3 Months Ended
	Feb. 28, 2015
NATURE OF BUSINESS AND BASIS OF PRESENTATION	1. NATURE OF BUSINESS AND BASIS OF PRESENTATION
	Nature of Business
	API Technologies Corp. (“API”, and together with its subsidiaries, the “Company”) designs, develops, and manufactures systems, subsystems, modules, and components for RF microwave, millimeterwave, electromagnetic, power, and security applications, as well as provides electronics manufacturing for technically demanding, high-reliability applications.
	On December 31, 2013, the Company completed the sale and leaseback (the “Sale/Leaseback”) of the Company’s facility located in State College, Pennsylvania. The Company sold the facility to an unaffiliated third party for a purchase price of approximately $15,500 and will lease the property from the buyer for approximately $1,279 per year, subject to annual adjustments. The Company used $14,200 of the proceeds of the Sale/Leaseback to prepay a portion of its outstanding term loan indebtedness.
	The unaudited consolidated financial statements include the accounts of API and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. There are no other entities controlled by the Company, either directly or indirectly. The financial statements have been prepared in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (the “SEC”).
	Accordingly, certain information and footnote disclosures required in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for the fair presentation of the Company’s consolidated financial position as of February 28, 2015 and the results of its operations and cash flows for the three month period ended February 28, 2015. Results for the interim period are not necessarily indicative of results that may be expected for the entire year or for any other interim periods. The unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company and the notes thereto as of and for the year ended November 30, 2014 included in the Company’s Form 10-K filed with the SEC on February 10, 2015.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Feb. 28, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Accounting Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements, and the disclosures made in the accompanying notes. Examples of estimates include the provisions made for bad debts and obsolete inventory, estimates associated with annual goodwill impairment tests, and estimates of deferred income tax and liabilities. The Company also uses estimates when assessing fair values of assets and liabilities acquired in business acquisitions as well as any fair value and any related impairment charges related to the carrying value of machinery and equipment, other long-lived assets and discontinued operations. The Company also uses estimates in determining the remaining economic lives of long-lived assets. In addition, the Company uses assumptions when employing the Black-Scholes valuation model to estimate the fair value of share options. Despite the Company’s intention to establish accurate estimates and use reasonable assumptions, actual results may differ from these estimates.
	Inventories
	Inventories, which include materials, labor, and manufacturing overhead, are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. On a quarterly basis, the Company evaluates inventories for potential write-down for identifiable obsolescence and slow moving items. The evaluation includes analysis of future demand, product mix and possible alternative uses. The Company records a provision for both excess and obsolete inventory when write-downs or write-offs are identified. Any write-down of inventory at the close of a fiscal period creates a new cost basis that subsequently would not be marked up based on changes in underlying facts and circumstances.
	The Company periodically reviews and analyzes its inventory management systems, and conducts inventory impairment testing on a quarterly basis.
	Fixed Assets
	Fixed assets are recorded at cost less accumulated depreciation and are depreciated using the straight-line method over the following periods:
	Straight line basis
	Buildings and leasehold improvements		5-40 years
	Computer equipment		3-5 years
	Furniture and fixtures		5-8 years
	Machinery and equipment		5-10 years
	Vehicles		3 years
	Betterments are capitalized and amortized by the Company, using the same amortization basis as the underlying assets over the remaining useful life of the original asset. Betterments include renovations, major repairs and upgrades that increase the service of a fixed asset and extend the useful life. Gains and losses on depreciable assets retired or sold are recognized in the consolidated statements of operations in the year of disposal. Repairs and maintenance expenditures are expensed as incurred.
	Goodwill and Intangible Assets
	Goodwill and intangible assets result primarily from business acquisitions accounted for under the purchase method. Goodwill and intangible assets with indefinite lives are not amortized but are subject to impairment by applying a fair value based test. The Company completes an annual (or more often if impairment indicators arise under the applicable accounting guidance) impairment assessment of its goodwill on a reporting unit level. The Company’s annual impairment test for goodwill is September 1st.
	Intangible assets that have a finite life are amortized using the following basis over the following periods:
	Non-compete agreements	Straight line over 5 years
	Computer software	Straight line over 3-5 years
	Customer related intangibles	Straight line or the pattern in which the economic benefits are expected to be realized, over an estimated life of 4-15 years
	Marketing related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 3-10 years
	Technology related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 10 years
	Long-Lived Assets
	The Company periodically evaluates the net realizable values of long-lived assets, principally identifiable intangibles and capital assets, for potential impairment when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, as determined based on the estimated future undiscounted cash flows. If such assets were considered to be impaired, the carrying value of the related assets would be reduced to their estimated fair value.
	Income Taxes
	Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial reporting and tax bases of assets and liabilities and available net operating loss carry forwards. A valuation allowance is established to reduce tax assets if it is more likely than not that all or some portions of such tax assets will not be realized.
	The Company’s valuation allowance was recorded on the deferred tax assets to provide for a reasonable provision, which in the Company’s estimation is more likely than not that all or some portions of such tax assets will not be realized. In determining the adequacy of the valuation allowance, the Company applied the authoritative guidance, and considered such factors as (i) which subsidiaries were producing income and which subsidiaries were producing losses and (ii) temporary differences occurring from depreciation and amortization which the Company expects to increase the taxable income over future periods.
	The Company follows the guidance concerning accounting for uncertainty in income taxes, which clarifies the accounting and disclosure for uncertainty in tax positions. The guidance requires that the Company determine whether it is more likely than not that a tax position will not be sustained upon examination by the appropriate taxing authority. If a tax position does not meet the more likely than not recognition criterion, the guidance requires that the tax position be measured at the largest amount of benefit greater than 50 percent not likely of being sustained upon ultimate settlement.
	Based on the Company’s evaluation, management has concluded that there are no significant uncertain tax positions requiring recognition in the consolidated financial statements or adjustments to deferred tax assets and related valuation allowance. Open tax years include the tax years ended January 21, 2011 through November 30, 2014.
	The Company from time to time has been assessed interest or penalties by major tax jurisdictions, however such assessments historically have been minimal and immaterial to our financial results. If the Company receives an assessment for interest and/or penalties, it would be classified in the consolidated financial statements as general and administrative expense.
	Revenue Recognition
	The Company recognizes non-contract revenue when it is realized and earned. The Company considers non-contract revenue realized or realizable and earned when it has persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. Delivery is not considered to have occurred until products have been shipped and risk of loss and ownership has transferred to the client. Revenue from production-type contracts, which represents less than one per cent of total revenue, is recognized using the percentage of completion method. The degree of completion is determined based on costs incurred, excluding costs that are not representative of progress to completion, as a percentage of total costs anticipated for each contract. A provision is made for losses on contracts in progress when such losses first become known. Revisions in cost and profit estimates, which can be significant, are reflected in the accounting period in which the relevant facts become known. Revenue from contracts under the percentage of completion method is not significant to the financial statements.
	Deferred Revenue
	The Company defers revenue when payment is received in advance of the service or product being shipped or delivered. For some of the larger government contracts, the Company will bill upon meeting certain milestones. These milestones are established by the customer and are specific to each contract. Unearned revenue is recorded as deferred revenue. The Company recognizes revenue on these larger government contracts when items are shipped or upon agreed milestones.
	Research and Development
	Research and development costs are expensed when incurred.
	Stock-Based Compensation
	The Company follows the authoritative guidance for accounting for stock-based compensation. The guidance requires that new, modified and unvested stock-based payment transactions with employees, such as grants of stock options, restricted stock units (“RSUs”) and restricted stock, be recognized in the financial statements based on their fair value at the grant date and recognized as compensation expense over their vesting periods. Stock-based compensation cost for RSUs is measured based on the closing fair market value of the Company’s common stock on the date of grant. The fair value of each option granted is estimated on the grant date using the Black-Scholes option pricing model which takes into account as of the grant date the exercise price and expected life of the option, the current price of the underlying shares and its expected volatility, expected dividends on the shares and the risk-free interest rate for the term of the option.
	Foreign Currency Translation and Transactions
	The Company’s functional currency is United States dollars and the consolidated financial statements are stated in United States dollars, “the reporting currency.” Integrated operations have been translated from various foreign currencies (Canadian dollars, British Pounds Sterling, Chinese Yuan, Euros, and Mexican Pesos) into United States dollars at the period-end exchange rate for monetary balance sheet items, the historical rate for fixed assets and shareholders’ equity, and the average exchange rate for the year for revenues, expenses, gains and losses. The gains or losses on translation are included as a component of other comprehensive income (loss) for the period.
	Financial Instruments
	The fair values of financial instruments including cash and cash equivalents, accounts receivable, accounts payable, and short-term borrowings approximate their carrying values due to the short-term nature of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest rate, currency or credit risks arising from its financial instruments. The recorded value of long-term debt approximates the fair value of the debt as the terms and rates approximate market rates.
	In the ordinary course of business, the Company carries out transactions in various foreign currencies (Canadian Dollars, British Pounds Sterling, Chinese Yuan, Euros, and Mexican Pesos) included in the Company’s cash, accounts receivable, accounts payable, bank indebtedness, as well as a mortgage loan. The translation adjustments related to these accounts have been reflected as a component of comprehensive income. Currently, the Company does not maintain a foreign currency hedging program.
	Debt Issuance Costs and Long-term Debt Discounts
	Fees paid to obtain debt financing or amendments under such debt financing are treated as debt issuance costs and are capitalized and amortized over the life of the debt using the effective interest method. These payments are shown as a financing activity on the consolidated statement of cash flows and are shown as other non-current assets in the consolidated balance sheets.
	The Company may record debt and equity discounts in connection with raising funds through the issuance of convertible notes or equity instruments. These discounts may arise from (i) the receipt of proceeds less than the face value of the convertible notes or equity instruments, (ii) beneficial conversion features and/or (iii) recording derivative liabilities related to embedded features. These costs are amortized over the life of the debt to interest expense utilizing the effective interest method. If a conversion of the underlying debt occurs, a proportionate share of the unamortized discount is immediately expensed.
	Concentration of Credit Risk
	The Company maintains cash balances, at times, with financial institutions, which are in excess of amounts insured by the Federal Deposit Insurance Corporation (FDIC), Canadian Deposit Insurance Corporation (CDIC) and Financial Services Compensation Scheme (FSCS in the United Kingdom). Management monitors the soundness of these institutions and has not experienced any collection losses with these institutions.
	The US, Canadian and United Kingdom Governments’ Departments of Defense (directly and through subcontractors) accounts for approximately 41%, 1% and 11% of the Company’s revenues for the three months ended February 28, 2015 (49%, 3% and 10% for the three months ended February 28, 2014), respectively. A loss of a significant customer could adversely impact the future operations of the Company.
	Earnings (Loss) per Share of Common Stock
	Basic earnings per share of common stock is computed by dividing income by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock gives effect to all dilutive potential shares of common stock outstanding during the period. The computation of diluted earnings per share does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings per share (Note 11).
	Comprehensive Income (Loss)
	Comprehensive income (loss), which includes foreign currency translation adjustments, is shown in the Consolidated Statement of Operations and Comprehensive Income (Loss).

EFFECTS_OF_RECENT_ACCOUNTING_P

EFFECTS OF RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Feb. 28, 2015
EFFECTS OF RECENT ACCOUNTING PRONOUNCEMENTS	3. EFFECTS OF RECENT ACCOUNTING PRONOUNCEMENTS
	Recently Issued Accounting Pronouncements
	In April 2014, the FASB issued guidance which changes the threshold for reporting discontinued operations and adds additional disclosures. The guidance updates the definition of discontinued operations to include the disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The guidance is effective prospectively for all disposals of components of an entity that occur with annual periods beginning on or after December 15, 2014, and interim periods therein. The Company is currently assessing the impact of this guidance on our consolidated financial position and results of operations.
	In May 2014, the FASB issued guidance which affects any entity using GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). The new guidance will supersede the existing revenue recognition requirements, and most industry-specific guidance. For a public entity, the amendments in this guidance are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. The guidance permits companies to either apply the requirements retrospectively to all prior periods presented or apply the requirements in the year of adoption, through a cumulative adjustment. The Company has not yet selected a transition method nor has it determined the impact of adoption on its condensed consolidated financial statements.

INVENTORIES

INVENTORIES	3 Months Ended
	Feb. 28, 2015
INVENTORIES	4. INVENTORIES
	Inventories consisted of the following:
		(in thousands)
		February 28,		November 30,
		2015		2014
	Raw materials	$	31,228	$	30,509
	Work in progress		17,641		16,130
	Finished goods		9,362		8,079
	Total	$	58,231	$	54,718
	At February 28, 2015 and November 30, 2014, inventories are presented net of inventory reserves of $9,159 and $8,990, respectively.

SHORTTERM_DEBT

SHORT-TERM DEBT	3 Months Ended
	Feb. 28, 2015
SHORT-TERM DEBT	5. SHORT-TERM DEBT
	The Company has a credit facility in place for certain of its U.K. subsidiaries for approximately $388 (250 GBP), which renews in July 2015. This line of credit is tied to the prime rate in the United Kingdom and is secured by the subsidiaries’ assets. This facility was undrawn as of February 28, 2015 and November 30, 2014.

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	3 Months Ended
	Feb. 28, 2015
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	6. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following:
		(in thousands)
		February 28,		November 30,
		2015		2014
	Trade accounts payable	$	18,884	$	16,843
	Accrued expenses		6,505		6,497
	Wage and vacation accrual		3,246		4,567
	Total	$	28,635	$	27,907

LongTerm_Debt

Long-Term Debt	3 Months Ended
	Feb. 28, 2015
Long-Term Debt	7. Long-Term Debt
	The Company had the following long-term debt obligations:
			(in thousands)
			February 28,			November 30,
			2015			2014
	Term loans, due February 6, 2018, base rate plus 6.50% interest or LIBOR plus 7.50%, (a)		$	119,266		$	121,730
	Mortgage loan, due 2027, 1.35% above Barclays fixed bank rate (b)			1,098			1,151
	Capital leases payable (c)			5,417			5,430
			$	125,781		$	128,311
	Less: Current portion of long-term debt			(10,916	)		(10,097	)
	Long-term portion		$	114,865		$	118,214
	a)	On February 6, 2013, the Company refinanced its credit facilities and entered into (i) a credit agreement (the “Term Loan Agreement”) with various lenders and Guggenheim Corporate Funding, LLC, as agent (the “Agent”) that provides for a $165,000 term loan facility and (ii) a credit agreement with various lenders and Wells Fargo Bank, National Association (the “Revolving Loan Agreement”) that provides for a $50,000 asset-based revolving borrowing base credit facility, with a $10,000 subfacility (or the Sterling equivalent) for certain of our United Kingdom subsidiaries, a $10,000 subfacility for letters of credit and a $5,000 subfacility for swingline loans.
	On February 6, 2013, in connection with entering into the Term Loan Agreement and the Revolving Loan Agreement, the Amended and Restated Credit Agreement, dated as of June 27, 2011 and amended on January 6, 2012 and March 22, 2012, by and among the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, lead arranger and sole book-runner, which had an outstanding balance of $183,400 was paid off and terminated, which resulted in the write-off of approximately $10,300 of deferred financing costs and note discounts.
	On December 31, 2013, the Company repaid $14,200 of its term loans from the proceeds of the Sale/Leaseback, (see (c) below) of the Company’s facility located in State College, Pennsylvania. On July 5, 2013 and April 17, 2013, the Company sold Data Bus and Sensors and repaid approximately $28,780 and $44,919, respectively, of its term loans from the proceeds of these sales, in accordance with the Term Loan Agreement. In addition, the Company repaid a portion of its term loans using the net proceeds of $739 from the March 14, 2013, sale of certain land and a building in Palm Bay, Florida.
	On May 22, 2013, the Company entered into a First Amendment to the Revolving Loan Agreement that amends certain cash management and reporting requirements.
	On October 10, 2013, the Company entered into an Amendment No. 1 to the Credit Agreement (the “Amendment No. 1”) by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 1, among other things, amends the Term Loan Agreement to reduce the minimum interest coverage ratio, increase the maximum leverage ratio, reduce the interest rate on the term loans and modify the terms of the prepayment premium, which the Company is required to pay upon voluntary prepayments or certain mandatory prepayments of the term loans.
	On March 21, 2014, the Company entered into Amendment No. 2 to the Credit Agreement (the “Amendment No. 2”), by and among the Company, as borrower, the lenders party thereto and the Agent.
	Amendment No. 2 amends the Term Loan Agreement to provide for an incremental term loan facility in an aggregate principal amount equal to $55,000 (the “Incremental Term Loan Facility”), which Incremental Term Loan Facility is subject to substantially the same terms and conditions, including the applicable interest rate and the maturity date of February 6, 2018, as the $165,000 term loan facility provided upon the initial closing of the Term Loan Agreement. In addition, Amendment No. 2 amends the Term Loan Agreement to reduce the minimum interest coverage ratio and increase the maximum leverage ratio, among other things.
	The proceeds of the Incremental Term Loan Facility were used (i) to pay in full and terminate the Company’s Revolving Loan Agreement; (ii) to redeem all 26,000 shares of the Company’s Series A Preferred Stock that were outstanding (as defined and described in Note 10); (iii) to pay fees, costs and expenses associated with the Incremental Term Loan Facility and related transactions; and (iv) for general corporate purposes. This resulted in the write-off of approximately $10,212 of deferred financing costs and note discounts in the quarter ended May 31, 2014.
	Term Loan Agreement
	The term loans incurred pursuant to the Term Loan Agreement, as amended, bear interest, at the Company’s option, at the base rate plus 6.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 7.50% for the first year and at the base rate plus 7.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 10.75% thereafter, with a LIBOR floor of 1.50%. For purposes of the Term Loan Agreement, the “base rate” means the highest of Wells Fargo Bank, National Association’s prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%.
	Interest is due and payable in arrears monthly for term loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of term loans with interest periods greater than three months) in the case of term loans bearing interest at the adjusted LIBOR rate. Principal payments of the term loans are paid at the end of each of the Company’s fiscal quarters, commencing for the fiscal quarter ending May 31, 2013, with the balance of any outstanding term loans due and payable in full on February 6, 2018. The quarterly principal payments will amortize at 1.25% for the fiscal quarters through the end of the Company’s 2014 fiscal year, at 1.875% for the fiscal quarters through the end of the Company’s 2015 fiscal year and at 2.50% for each of the fiscal quarters thereafter.
	Under certain circumstances, the Company is required to prepay the term loans upon the receipt of cash proceeds of certain asset sales, cash proceeds of certain extraordinary receipts and cash proceeds of certain debt or equity financings, and based on a calculation of annual excess cash flow. Mandatory prepayments resulting from assets sales or certain debt financings may require the payment of certain prepayment premiums.
	The term loans are secured by a first priority security interest in accounts receivable, inventory, machinery, equipment and certain other personal property relating to the foregoing, and any proceeds from any of the foregoing, subject to certain exceptions and liens, and a first priority security position on substantially all other real and personal property, in each case that are owned by the Company and the subsidiary guarantors.
	The Term Loan Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company and its subsidiaries’ ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a term loan of this size and type.
	Pursuant to the Term Loan Agreement, the Company is required to maintain compliance with an interest coverage ratio and a leverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights).
	Revolving Loan Agreement
	On March 21, 2014, approximately $25,136 of the proceeds of the Incremental Term Loan Facility were used to pay in full and terminate the Company’s Revolving Loan Agreement.
	The revolving loans incurred pursuant to the Revolving Loan Agreement bore interest, at the Company’s option, at the base rate plus a margin between 1.50% and 2.00% or an adjusted LIBOR rate (based on one, two, three or six-month interest periods) plus a margin between 2.50% and 3.00%, in each case with such margin being determined based on the Company’s average daily excess availability under the revolving credit facility for the preceding fiscal quarter. For purposes of the Revolving Loan Agreement, the “base rate” means the highest of Wells Fargo Bank, National Association’s prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%.
	Interest was due and payable in arrears monthly for revolving loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of revolving loans bearing interest at the adjusted LIBOR rate. Principal, together with all accrued and unpaid interest, would have been due and payable on February 6, 2018. The Company was permitted to prepay the revolving loans and terminate the commitments, in whole or in part, at any time without premium or penalty. Under certain circumstances, the Company was required to prepay the revolving loans upon the receipt of cash proceeds of certain asset sales.
	All borrowings under the Revolving Loan Agreement were limited by amounts available pursuant to a borrowing base calculation, which was based on percentages of eligible accounts receivable, inventory, machinery and equipment, in each case subject to reductions for applicable reserves.
	The Revolving Loan Agreement contained customary affirmative and negative covenants, including covenants that limited or restricted the Company and its subsidiaries’ ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a credit facility of this size and type.
	Pursuant to the Revolving Loan Agreement, the Company was also required to maintain compliance with a fixed charge coverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights) at such times that it failed to maintain excess availability under the revolving credit facility above a specified level.
	b)	A subsidiary of the Company in the United Kingdom entered into a 20 year term mortgage agreement in 2007, under which interest is charged at a margin of 1.35% over Barclays Fixed Base Rate of 0.5% at February 28, 2015. The mortgage is secured by the subsidiary’s assets.
	c)	On December 31, 2013, the Company completed the Sale/Leaseback. The Company sold the facility to an unaffiliated third party for a gross purchase price of approximately $15,500 and will lease the property from the buyer for approximately $1,279 per year, subject to annual adjustments. As a result of this transaction the Company initially recorded a capital lease obligation of $5,225. The gain on the sale has been deferred and is being recognized over the 15 year lease term.

SHAREHOLDERS_EQUITY

SHAREHOLDERS' EQUITY	3 Months Ended
	Feb. 28, 2015
SHAREHOLDERS' EQUITY	8. SHAREHOLDERS’ EQUITY
	On January 20, 2010 the Company agreed to issue 800,000 shares of API common stock payable as part of the compensation to Kuchera Defense Systems, Inc. (“KDS”), KII, Inc. (“KII”) and Kuchera Industries, LLC (“KI Industries” and collectively with KDS and KII, the “KGC Companies”) or their designees. 250,000 shares were issued and delivered at closing, 250,000 shares were to be issued and delivered on the first anniversary of the closing and 300,000 shares were to be issued and delivered on the second anniversary of the closing. The Company has issued 126,250 shares in escrow from the remaining 550,000 shares. Three API subsidiaries have claimed a right of set off against the escrowed shares under the asset purchase agreement with respect to claimed amounts due to the Company under the indemnification provisions of the asset purchase agreement. The unissued shares have been accounted for as common shares subscribed but not issued. In addition, on January 20, 2010 and January 22, 2010, we issued warrants to purchase an aggregate of 892,862 shares of common stock with an exercise price of $5.60 per share, which expired on January 20, 2015 and January 22, 2015.
	In connection with the Plan of Arrangement that occurred on November 6, 2006, the Company was obligated to issue 2,354,505 shares of either API common stock or exchangeable shares of API Nanotronics Sub, Inc. in exchange for the API Electronics Group Corp. common shares previously outstanding. As of February 28, 2015, API is obligated to issue a remaining approximately 63,886 shares of its common stock under the Plan of Arrangement either directly for API common shares or in exchange for API Nanotronics Sub, Inc. exchangeable shares not held by API or its affiliates. There are 22,617 exchangeable shares outstanding (excluding exchangeable shares held by the Company) as of February 28, 2015. Exchangeable shares are substantially equivalent to our common shares.
	On November 6, 2006, API amended its certificate of incorporation to allow it to issue one special voting share. This special voting share was issued to a trustee in connection with a Plan of Arrangement and allows the trustee to have at meetings of stockholders of API the number of votes equal to the number of exchangeable shares not held by API or subsidiaries of API. (The trustee is charged with obtaining the direction of the holders of exchangeable shares on how to vote at meetings of API stockholders.) The API Nanotronics Sub, Inc. exchangeable shares are convertible into shares of API common stock at any time at the option of the holder. API may force the conversion of API Nanotronics Sub., Inc. exchangeable shares into shares of API common stock on the tenth anniversary of the date of the Plan of Arrangement or sooner upon the happening of certain events.
	The Company, as of March 21, 2014, redeemed all 26,000 shares of its outstanding Series A Preferred Stock. Following the redemption, all shares of Series A Preferred Stock were cancelled and such shares were returned to authorized but undesignated shares of the Company’s preferred stock.
	The Company issued no options or RSUs during three months ended February 28, 2015 and 2014, respectively (Note 9). The Company values its option grants using the Black-Scholes option-pricing model.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Feb. 28, 2015
STOCK-BASED COMPENSATION	9. STOCK-BASED COMPENSATION
	Of the 5,875,000 shares authorized under the Equity Incentive Plan, 3,752,072 shares are available for issuance pursuant to options, RSUs, or stock as of February 28, 2015. Under the Company’s Equity Incentive Plan, incentive options and non-statutory options may have a term of up to ten years from the date of grant. The stock option exercise prices are equal to at least 100 percent of the fair market value of the underlying shares on the date the options are granted.
	As of February 28, 2015 there was $197 of total unrecognized compensation related to non-vested stock options, which are not contingent upon attainment of certain milestones. The cost is expected to be recognized over the remaining periods of the options, which are expected to vest from 2014 to 2017.
	During the three months ended February 28, 2015 and 2014, $79 and ($48), respectively, has been recognized as stock-based compensation expense in general and administrative expense.
	The summary of the common stock options granted, cancelled, exchanged or exercised under the Plan:
		Options			Weighted
					Average
					Exercise
					Price
	Stock Options outstanding— November 30, 2013		1,848,485		$	4.98
	Less forfeited		(765,175	)	$	4.9
	Exercised		—		$	—
	Issued		245,000		$	2.23
	Stock Options outstanding—November 30, 2014		1,328,310		$	4.52
	Less forfeited		(12,683	)	$	5.26
	Exercised		—		$	—
	Issued		—		$	—
	Stock Options outstanding—February 28, 2015		1,315,627		$	4.52
	Stock Options exercisable— February 28, 2015		1,065,211		$	5.05
	Restricted stock unit activity under the 2006 Equity Compensation Plan is presented below:
		Units			Weighted
					Average
					Grant
					Date Fair
					Value
	RSUs outstanding— November 30, 2013		81,667		$	3.72
	Issued		15,000		$	2.37
	Exercised—Stock issued		(48,333	)	$	3.72
	RSUs outstanding—November 30, 2014		48,334		$	3.3
	Issued		—		$	—
	Exercised—Stock issued		—		$	—
	RSUs outstanding— February 28, 2015		48,334		$	3.3
	RSUs exercisable— February 28, 2015		—		$	—
		RSUs and Options Outstanding									RSUs and Options Exercisable
	Range of	Number of			Weighted		Weighted		Aggregate		Number		Weighted		Aggregate
	Exercise Price	Outstanding			Average		Average		Intrinsic		Exercisable		Average		Intrinsic
		at Feb. 28,			Exercise		Remaining		Value		at Feb. 28,		Exercise		Value
		2015			Price		Life		(in thousands)		2015		Price		(in thousands)
							(Years)
	$0.00 – $ 3.55		690,834		$	2.83		7.65	$	94		397,500	$	3.54	$	—
	$3.56 – $ 4.99		27,084		$	3.56		5.65	$	—		21,668	$	3.56	$	—
	$5.00 – $ 6.99		640,209		$	5.95		5.59	$	—		640,209	$	5.95	$	—
	$7.00 – $ 20.00		5,834		$	14.07		2.24	$	—		5,834	$	14.07	$	—
			1,363,961					6.62	$	94		1,065,211			$	—
	The intrinsic value is calculated as the excess of the market value as of February 28, 2015 over the exercise price of the shares. The market value as of February 28, 2015 was $1.94 as reported by the NASDAQ Stock Market.

SUPPLEMENTAL_CASH_FLOW_INFORMA

SUPPLEMENTAL CASH FLOW INFORMATION	3 Months Ended
	Feb. 28, 2015
SUPPLEMENTAL CASH FLOW INFORMATION	10. SUPPLEMENTAL CASH FLOW INFORMATION
	Supplemental cash flow information:
		(in thousands)
		Three months ended
		February 28,		February 28,
		2015		2014
	Supplemental Cash Flow Information
	Cash paid for income taxes	$	220	$	244
	Cash paid for interest	$	2,792	$	1,711
	Capital lease obligation	$	—	$	5,225
	In February 2014, the Company received $1,414 related to a tax refund from the acquisition of one of its subsidiaries, SenDEC Corporation.

EARNINGS_PER_SHARE_OF_COMMON_S

EARNINGS PER SHARE OF COMMON STOCK	3 Months Ended
	Feb. 28, 2015
EARNINGS PER SHARE OF COMMON STOCK	11. EARNINGS PER SHARE OF COMMON STOCK
	The following table sets forth the computation of weighted-average shares outstanding for calculating basic and diluted earnings per share (EPS):
			Three months ended
			February 28
			2015		2014
	Weighted average shares-basic			55,461,217		55,426,635
	Effect of dilutive securities			*		*
	Weighted average shares—diluted			55,461,217		55,426,635
	Basic EPS and diluted EPS for the three months ended February 28, 2015 and 2014 have been computed by dividing the net income (loss) by the weighted average shares outstanding. The weighted average numbers of shares of common stock outstanding includes exchangeable shares and shares to be issued under the Plan of Arrangement.
	*	Outstanding options and RSUs aggregating 1,363,961 – February 28, 2015 (1,756,937 – February 28, 2014) incremental shares, and 892,862 warrants at February 28, 2014 have been excluded from the February 28, 2015 and 2014 computation of diluted EPS as they are anti-dilutive due to the losses generated in each respective period.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Feb. 28, 2015
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES
	On September 15, 2011, Currency, Inc., KII Inc., Kuchera Industries, LLC, William Kuchera and Ronald Kuchera (the “Plaintiffs”) filed a lawsuit against API and three API subsidiaries (the “API Pennsylvania Subsidiaries”) in the Court of Chancery of the State of Delaware in relation to the Asset Purchase Agreement by and among API, the API Pennsylvania Subsidiaries, the KGC Companies, William Kuchera, and Ronald Kuchera dated January 20, 2010. Plaintiffs’ complaint alleges claims for breach of contract and unjust enrichment based on their contention that API and the API Pennsylvania Subsidiaries violated the Asset Purchase Agreement by failing to issue certain shares of stock to Plaintiffs and by failing to cooperate with Plaintiffs in the filing of a final general and administrative overhead rate with the Defense Contracting Audit Agency. API and the API Pennsylvania Subsidiaries filed an answer to the complaint denying all liability and a counterclaim for breach of contract against Plaintiffs. The final outcome and impact of this matter is subject to many variables, and cannot be predicted. Of the 550,000 shares that have not been delivered under the Asset Purchase Agreement, 126,250 were placed in escrow and the remaining 423,750 shares have been accounted for as common shares subscribed but not issued with a value of $2,373.
	The Company is also a party to lawsuits in the normal course of its business. Litigation can be unforeseeable, expensive, lengthy and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict. An unfavorable resolution of a particular lawsuit could have a material adverse effect on the Company’s business, operating results, or financial condition.
	In accordance with required guidance, the Company accrues for litigation matters when losses become probable and reasonably estimable. The Company has no recorded accrual relating to its outstanding legal matters as of February 28, 2015 (November 30, 2014—$0). As of the end of each applicable reporting period, or more frequently, as necessary, the Company reviews each outstanding matter and, where it is probable that a liability has been incurred, it accrues for all probable and reasonably estimable losses. Where the Company is able to reasonably estimate a range of losses with respect to such a matter, it records an accrual for the amount within the range that constitutes its best estimate. If the Company can reasonably estimate a range but no amount within the range appears to be a better estimate than any other, it will use the amount that is the low end of such range. Because of the uncertainty, the complexity and the many variables involved in litigation, the actual costs to the Company with respect to its legal matters may differ from our estimates, could result in a significant difference and could have a material adverse effect on the Company’s financial position, liquidity, or results of operations. If we determine that an additional loss in excess of our accrual is probable but not estimable, the Company will provide disclosure to that effect. The Company expenses legal costs as they are incurred.

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Feb. 28, 2015
INCOME TAXES	13. INCOME TAXES
	For the three month periods ended February 28, 2015 and 2014, the Company’s effective income tax rates were (14.2)% and (31.3)% for continuing operations, respectively compared to an applicable U.S. federal statutory income tax rate of 34%. The difference between the effective tax rate and U.S. statutory tax as of February 28, 2015 and February 28, 2014 is primarily due to existence of valuation allowance for deferred tax assets including net operating losses and income from foreign subsidiaries taxed at rates lower than the U.S. statutory rate. For the three months ended February 28, 2015, the Company recorded valuation allowances on deferred tax assets relating to current year losses and for the accrual of non-cash tax expense due to additional valuation allowances in connection with the tax amortization of our indefinite-lived intangible assets that was not available to offset existing deferred tax assets.
	As of February 28, 2015, the Company had no significant unrecognized tax benefits.
	The Company records interest and penalties related to tax matters within general and administrative expenses on the accompanying Consolidated Statement of Operations. These amounts are not material to the consolidated financial statements for the periods presented. The Company’s U.S. tax returns are subject to examination by federal and state taxing authorities. Generally, tax years 2011-2014 remain open to examination by the Internal Revenue Service or other tax jurisdictions to which the Company is subject. The Company’s Canadian tax returns are subject to examination by federal and provincial taxing authorities in Canada. Generally, tax years 2011-2014 remain open to examination by Canada Revenue Agency or other tax jurisdictions to which the Company is subject.

RESTRUCTURING_CHARGES_RELATED_

RESTRUCTURING CHARGES RELATED TO CONSOLIDATION OF OPERATIONS	3 Months Ended
	Feb. 28, 2015
RESTRUCTURING CHARGES RELATED TO CONSOLIDATION OF OPERATIONS	14. RESTRUCTURING CHARGES RELATED TO CONSOLIDATION OF OPERATIONS
	In accordance with accounting guidance for costs associated with asset exit or disposal activities, restructuring costs are recorded as incurred. Restructuring charges for employee workforce reductions are recorded upon employee notification.
	a) Ottawa restructuring
	In November 2013, the Company commenced the restructuring of a portion of its Ottawa, Ontario, Canada business (“Ottawa restructuring”), which included the movement of certain operations to its State College facility, in order to improve its profitability. The actions taken as part of the Ottawa restructuring are intended to realize synergies from our combined SSC operations, contain costs and streamline our operations. Elements of the Ottawa restructuring include management re-alignment, workforce reductions and write-downs and charges related to inventory and relocation costs. The Ottawa restructuring was substantially completed by May 31, 2014. As a result of the Ottawa restructuring, the Company reduced its SSC workforce by approximately 4%, which represents approximately 3% of its global workforce.
	The Company has recorded $2,047 of cumulative salary and related charges for the Ottawa restructuring in fiscal 2014 and 2013. As at February 28, 2015, $112 is included in accounts payable and accrued liabilities.
	b) EMS restructuring
	In June 2012, the Company announced the restructuring of its EMS business (“EMS restructuring”) in order to improve its profitability. The actions taken as part of the EMS restructuring were intended to realize synergies from our combined EMS operations, contain costs, reduce our exposure to low margin and unprofitable revenue streams within the EMS businesses, and streamline our operations. Elements of the EMS restructuring include management re-alignment, workforce reductions and write-downs and charges related to inventory, fixed assets, and long-term leases. The EMS restructuring was substantially completed by the end of fiscal 2012. As of November 30, 2012, the Company reduced its EMS workforce by approximately 10%, which represented approximately 2% of its global workforce.
	During the period ending November 30, 2012, the Company incurred approximately $591 related to cash outlays, primarily due to employee separation expenses. The majority of the non-cash charges are primarily related to the write-down of inventory related to the EMS product offerings, leasehold impairments and fixed asset impairments.
	The following tables summarize the charges related to EMS restructuring activities by type of cost:
		EMS
		Restructuring
		(in thousands)
	Salary and related charges	$	591
	Inventory write-down		7,401
	Fixed asset impairment		865
	Lease impairment		3,672
	Accumulated restructuring charges at November 30, 2012		12,529
	Cash payments		(591	)
	Non-cash charges		(10,028	)
	Balance – Lease impairment accrual, February 28, 2015	$	1,910
	During the three months ended February 28, 2015, the Company has reflected within the consolidated statement of operations restructuring charges of $872, which includes $326 related to specific restructuring events and $546 related to recruiting costs for the Company’s new Chief Executive Officer.

SEGMENT_INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Feb. 28, 2015
SEGMENT INFORMATION	15. SEGMENT INFORMATION
	The Company follows the authoritative guidance on the required disclosures for segments, which establish standards for the way that public business enterprises report information about operating segments in annual financial statements and requires that those enterprises report selected information about operating segments in financial reports. The guidance also establishes standards for related disclosures about products, geographic areas and major customers.
	The authoritative accounting guidance uses a management approach for determining segments. The management approach designates the internal organization that is used by management for making operating decisions and assessing performance as the source of the Company’s reportable segments. The Company’s operations are conducted in three principal business segments: Systems, Subsystems & Components (SSC), Secure Systems & Information Assurance (SSIA) and Electronic Manufacturing Services (EMS). Inter-segment sales are presented at their market value for disclosure purposes. Corporate includes general and administrative functions and unallocated costs of our shared service operations/management, administrative and other shared corporate services functions such as information technology, legal, finance, human resources, and marketing. These administrative and other shared services costs have been allocated in the adjusted EBITDA measure based on a percent of revenue for each respective operating segment.
	During the quarter ended February 28, 2014, the Company changed its reported basis of measurement of segment profit or loss. The Company’s chief operating decision maker evaluates segment performance based primarily on revenues and Adjusted EBITDA. The accounting policies of each of the operating segments are the same as those described in the summary of significant accounting policies in Note 2. Adjusted EBITDA represents income from continuing operations excluding depreciation and amortization, stock-based compensation expense and other items as described below. Management views adjusted EBITDA as an important measure of segment performance because it removes from operating results the impact of items that management believes do not reflect the Company’s core operating performance. Adjusted EBITDA is a measure which is also used in calculating financial ratios in material debt covenants in the Company’s credit facilities.
	Management does not evaluate the performance of its operating segments using asset measures. The identifiable assets by segment disclosed in this note are those assets specifically identifiable within each segment and include cash, accounts receivable, inventory, goodwill and intangible assets.
	Three months ended February 28, 2015		SSC		SSIA		EMS		Corporate		Inter		Total
											Segment
	(in thousands)										Eliminations
	Revenue from external customers		$	38,386	$	4,258	$	8,206	$	—	$	—	$	50,850
	Adjusted EBITDA:			5,242		755		50		—		—		6,047
	Acquisition related charges													62
	Restructuring													872
	Depreciation and amortization													3,459
	Interest expense, net													3,127
	Amortization of note discounts and deferred financing costs													23
	Other adjustments *													411
	Loss before income taxes												$	(1,907	)
	Segment assets—as at February 28, 2015		$	240,496	$	11,670	$	25,187	$	1,382	$	—	$	278,735
	Goodwill included in assets—as at Feb. 28, 2015		$	114,301	$	—	$	2,469	$	—	$	—	$	116,770
	Purchase of fixed assets, to February 28, 2015		$	144	$	12	$	3	$	—	$	—	$	159
	Three months ended February 28, 2014		SSC		SSIA		EMS		Corporate		Inter		Total
											Segment
	(in thousands)										Eliminations
	Revenue from external customers		$	39,661	$	5,399	$	13,858	$	—	$	—	$	58,918
	Adjusted EBITDA:			4,390		1,081		1,023		—		—		6,494
	Acquisition related charges													110
	Restructuring													417
	Depreciation and amortization													4,130
	Interest expense, net													2,410
	Amortization of note discounts and deferred financing costs													665
	Other adjustments *													380
	Loss before income taxes												$	(1,618	)
	Segment assets—as at November 30, 2014		$	241,246	$	13,183	$	24,235	$	4,176	$	—	$	282,840
	Goodwill included in assets—as at Nov. 30, 2014		$	114,301	$	—	$	2,469	$	—	$	—	$	116,770
	Purchase of fixed assets, to February 28, 2014		$	63	$	15	$	27	$	—	$	—	$	105
	*	Other adjustments primarily include non-cash inventory provisions, stock based compensation, franchise taxes, financing and other adjustments, lease payments for the State College, Pennsylvania facility, foreign exchange losses and a change in benefit liability.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Feb. 28, 2015
Accounting Estimates	Accounting Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements, and the disclosures made in the accompanying notes. Examples of estimates include the provisions made for bad debts and obsolete inventory, estimates associated with annual goodwill impairment tests, and estimates of deferred income tax and liabilities. The Company also uses estimates when assessing fair values of assets and liabilities acquired in business acquisitions as well as any fair value and any related impairment charges related to the carrying value of machinery and equipment, other long-lived assets and discontinued operations. The Company also uses estimates in determining the remaining economic lives of long-lived assets. In addition, the Company uses assumptions when employing the Black-Scholes valuation model to estimate the fair value of share options. Despite the Company’s intention to establish accurate estimates and use reasonable assumptions, actual results may differ from these estimates.
Inventories	Inventories
	Inventories, which include materials, labor, and manufacturing overhead, are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. On a quarterly basis, the Company evaluates inventories for potential write-down for identifiable obsolescence and slow moving items. The evaluation includes analysis of future demand, product mix and possible alternative uses. The Company records a provision for both excess and obsolete inventory when write-downs or write-offs are identified. Any write-down of inventory at the close of a fiscal period creates a new cost basis that subsequently would not be marked up based on changes in underlying facts and circumstances.
	The Company periodically reviews and analyzes its inventory management systems, and conducts inventory impairment testing on a quarterly basis.
Fixed Assets	Fixed Assets
	Fixed assets are recorded at cost less accumulated depreciation and are depreciated using the straight-line method over the following periods:
	Straight line basis
	Buildings and leasehold improvements		5-40 years
	Computer equipment		3-5 years
	Furniture and fixtures		5-8 years
	Machinery and equipment		5-10 years
	Vehicles		3 years
	Betterments are capitalized and amortized by the Company, using the same amortization basis as the underlying assets over the remaining useful life of the original asset. Betterments include renovations, major repairs and upgrades that increase the service of a fixed asset and extend the useful life. Gains and losses on depreciable assets retired or sold are recognized in the consolidated statements of operations in the year of disposal. Repairs and maintenance expenditures are expensed as incurred.
Goodwill and Intangible Assets	Goodwill and Intangible Assets
	Goodwill and intangible assets result primarily from business acquisitions accounted for under the purchase method. Goodwill and intangible assets with indefinite lives are not amortized but are subject to impairment by applying a fair value based test. The Company completes an annual (or more often if impairment indicators arise under the applicable accounting guidance) impairment assessment of its goodwill on a reporting unit level. The Company’s annual impairment test for goodwill is September 1st.
	Intangible assets that have a finite life are amortized using the following basis over the following periods:
	Non-compete agreements	Straight line over 5 years
	Computer software	Straight line over 3-5 years
	Customer related intangibles	Straight line or the pattern in which the economic benefits are expected to be realized, over an estimated life of 4-15 years
	Marketing related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 3-10 years
	Technology related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 10 years
Long-Lived Assets	Long-Lived Assets
	The Company periodically evaluates the net realizable values of long-lived assets, principally identifiable intangibles and capital assets, for potential impairment when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, as determined based on the estimated future undiscounted cash flows. If such assets were considered to be impaired, the carrying value of the related assets would be reduced to their estimated fair value.
Income Taxes	Income Taxes
	Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial reporting and tax bases of assets and liabilities and available net operating loss carry forwards. A valuation allowance is established to reduce tax assets if it is more likely than not that all or some portions of such tax assets will not be realized.
	The Company’s valuation allowance was recorded on the deferred tax assets to provide for a reasonable provision, which in the Company’s estimation is more likely than not that all or some portions of such tax assets will not be realized. In determining the adequacy of the valuation allowance, the Company applied the authoritative guidance, and considered such factors as (i) which subsidiaries were producing income and which subsidiaries were producing losses and (ii) temporary differences occurring from depreciation and amortization which the Company expects to increase the taxable income over future periods.
	The Company follows the guidance concerning accounting for uncertainty in income taxes, which clarifies the accounting and disclosure for uncertainty in tax positions. The guidance requires that the Company determine whether it is more likely than not that a tax position will not be sustained upon examination by the appropriate taxing authority. If a tax position does not meet the more likely than not recognition criterion, the guidance requires that the tax position be measured at the largest amount of benefit greater than 50 percent not likely of being sustained upon ultimate settlement.
	Based on the Company’s evaluation, management has concluded that there are no significant uncertain tax positions requiring recognition in the consolidated financial statements or adjustments to deferred tax assets and related valuation allowance. Open tax years include the tax years ended January 21, 2011 through November 30, 2014.
	The Company from time to time has been assessed interest or penalties by major tax jurisdictions, however such assessments historically have been minimal and immaterial to our financial results. If the Company receives an assessment for interest and/or penalties, it would be classified in the consolidated financial statements as general and administrative expense.
Revenue Recognition	Revenue Recognition
	The Company recognizes non-contract revenue when it is realized and earned. The Company considers non-contract revenue realized or realizable and earned when it has persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. Delivery is not considered to have occurred until products have been shipped and risk of loss and ownership has transferred to the client. Revenue from production-type contracts, which represents less than one per cent of total revenue, is recognized using the percentage of completion method. The degree of completion is determined based on costs incurred, excluding costs that are not representative of progress to completion, as a percentage of total costs anticipated for each contract. A provision is made for losses on contracts in progress when such losses first become known. Revisions in cost and profit estimates, which can be significant, are reflected in the accounting period in which the relevant facts become known. Revenue from contracts under the percentage of completion method is not significant to the financial statements.
Deferred Revenue	Deferred Revenue
	The Company defers revenue when payment is received in advance of the service or product being shipped or delivered. For some of the larger government contracts, the Company will bill upon meeting certain milestones. These milestones are established by the customer and are specific to each contract. Unearned revenue is recorded as deferred revenue. The Company recognizes revenue on these larger government contracts when items are shipped or upon agreed milestones.
Research and Development	Research and Development
	Research and development costs are expensed when incurred.
Stock-Based Compensation	Stock-Based Compensation
	The Company follows the authoritative guidance for accounting for stock-based compensation. The guidance requires that new, modified and unvested stock-based payment transactions with employees, such as grants of stock options, restricted stock units (“RSUs”) and restricted stock, be recognized in the financial statements based on their fair value at the grant date and recognized as compensation expense over their vesting periods. Stock-based compensation cost for RSUs is measured based on the closing fair market value of the Company’s common stock on the date of grant. The fair value of each option granted is estimated on the grant date using the Black-Scholes option pricing model which takes into account as of the grant date the exercise price and expected life of the option, the current price of the underlying shares and its expected volatility, expected dividends on the shares and the risk-free interest rate for the term of the option.
Foreign Currency Translation and Transactions	Foreign Currency Translation and Transactions
	The Company’s functional currency is United States dollars and the consolidated financial statements are stated in United States dollars, “the reporting currency.” Integrated operations have been translated from various foreign currencies (Canadian dollars, British Pounds Sterling, Chinese Yuan, Euros, and Mexican Pesos) into United States dollars at the period-end exchange rate for monetary balance sheet items, the historical rate for fixed assets and shareholders’ equity, and the average exchange rate for the year for revenues, expenses, gains and losses. The gains or losses on translation are included as a component of other comprehensive income (loss) for the period.
Financial Instruments	Financial Instruments
	The fair values of financial instruments including cash and cash equivalents, accounts receivable, accounts payable, and short-term borrowings approximate their carrying values due to the short-term nature of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest rate, currency or credit risks arising from its financial instruments. The recorded value of long-term debt approximates the fair value of the debt as the terms and rates approximate market rates.
	In the ordinary course of business, the Company carries out transactions in various foreign currencies (Canadian Dollars, British Pounds Sterling, Chinese Yuan, Euros, and Mexican Pesos) included in the Company’s cash, accounts receivable, accounts payable, bank indebtedness, as well as a mortgage loan. The translation adjustments related to these accounts have been reflected as a component of comprehensive income. Currently, the Company does not maintain a foreign currency hedging program.
Debt Issuance Costs and Long-term Debt Discounts	Debt Issuance Costs and Long-term Debt Discounts
	Fees paid to obtain debt financing or amendments under such debt financing are treated as debt issuance costs and are capitalized and amortized over the life of the debt using the effective interest method. These payments are shown as a financing activity on the consolidated statement of cash flows and are shown as other non-current assets in the consolidated balance sheets.
	The Company may record debt and equity discounts in connection with raising funds through the issuance of convertible notes or equity instruments. These discounts may arise from (i) the receipt of proceeds less than the face value of the convertible notes or equity instruments, (ii) beneficial conversion features and/or (iii) recording derivative liabilities related to embedded features. These costs are amortized over the life of the debt to interest expense utilizing the effective interest method. If a conversion of the underlying debt occurs, a proportionate share of the unamortized discount is immediately expensed.
Concentration of Credit Risk	Concentration of Credit Risk
	The Company maintains cash balances, at times, with financial institutions, which are in excess of amounts insured by the Federal Deposit Insurance Corporation (FDIC), Canadian Deposit Insurance Corporation (CDIC) and Financial Services Compensation Scheme (FSCS in the United Kingdom). Management monitors the soundness of these institutions and has not experienced any collection losses with these institutions.
	The US, Canadian and United Kingdom Governments’ Departments of Defense (directly and through subcontractors) accounts for approximately 41%, 1% and 11% of the Company’s revenues for the three months ended February 28, 2015 (49%, 3% and 10% for the three months ended February 28, 2014), respectively. A loss of a significant customer could adversely impact the future operations of the Company.
Earnings (Loss) per Share of Common Stock	Earnings (Loss) per Share of Common Stock
	Basic earnings per share of common stock is computed by dividing income by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock gives effect to all dilutive potential shares of common stock outstanding during the period. The computation of diluted earnings per share does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings per share (Note 11).
Comprehensive Income (Loss)	Comprehensive Income (Loss)
	Comprehensive income (loss), which includes foreign currency translation adjustments, is shown in the Consolidated Statement of Operations and Comprehensive Income (Loss).

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Feb. 28, 2015
Useful Life	Fixed assets are recorded at cost less accumulated depreciation and are depreciated using the straight-line method over the following periods:
	Straight line basis
	Buildings and leasehold improvements		5-40 years
	Computer equipment		3-5 years
	Furniture and fixtures		5-8 years
	Machinery and equipment		5-10 years
	Vehicles		3 years
Intangible Assets Finite Life	Intangible assets that have a finite life are amortized using the following basis over the following periods:
	Non-compete agreements	Straight line over 5 years
	Computer software	Straight line over 3-5 years
	Customer related intangibles	Straight line or the pattern in which the economic benefits are expected to be realized, over an estimated life of 4-15 years
	Marketing related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 3-10 years
	Technology related intangibles	The pattern in which the economic benefits are expected to be realized, over an estimated life of 10 years

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
	Feb. 28, 2015
Summary of Inventories	Inventories consisted of the following:
		(in thousands)
		February 28,		November 30,
		2015		2014
	Raw materials	$	31,228	$	30,509
	Work in progress		17,641		16,130
	Finished goods		9,362		8,079
	Total	$	58,231	$	54,718

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	3 Months Ended
	Feb. 28, 2015
Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consisted of the following:
		(in thousands)
		February 28,		November 30,
		2015		2014
	Trade accounts payable	$	18,884	$	16,843
	Accrued expenses		6,505		6,497
	Wage and vacation accrual		3,246		4,567
	Total	$	28,635	$	27,907

LongTerm_Debt_Tables

Long-Term Debt (Tables)	3 Months Ended
	Feb. 28, 2015
Long-Term Debt Obligation	The Company had the following long-term debt obligations:
			(in thousands)
			February 28,			November 30,
			2015			2014
	Term loans, due February 6, 2018, base rate plus 6.50% interest or LIBOR plus 7.50%, (a)		$	119,266		$	121,730
	Mortgage loan, due 2027, 1.35% above Barclays fixed bank rate (b)			1,098			1,151
	Capital leases payable (c)			5,417			5,430
			$	125,781		$	128,311
	Less: Current portion of long-term debt			(10,916	)		(10,097	)
	Long-term portion		$	114,865		$	118,214
	a)	On February 6, 2013, the Company refinanced its credit facilities and entered into (i) a credit agreement (the “Term Loan Agreement”) with various lenders and Guggenheim Corporate Funding, LLC, as agent (the “Agent”) that provides for a $165,000 term loan facility and (ii) a credit agreement with various lenders and Wells Fargo Bank, National Association (the “Revolving Loan Agreement”) that provides for a $50,000 asset-based revolving borrowing base credit facility, with a $10,000 subfacility (or the Sterling equivalent) for certain of our United Kingdom subsidiaries, a $10,000 subfacility for letters of credit and a $5,000 subfacility for swingline loans.
	On February 6, 2013, in connection with entering into the Term Loan Agreement and the Revolving Loan Agreement, the Amended and Restated Credit Agreement, dated as of June 27, 2011 and amended on January 6, 2012 and March 22, 2012, by and among the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, lead arranger and sole book-runner, which had an outstanding balance of $183,400 was paid off and terminated, which resulted in the write-off of approximately $10,300 of deferred financing costs and note discounts.
	On December 31, 2013, the Company repaid $14,200 of its term loans from the proceeds of the Sale/Leaseback, (see (c) below) of the Company’s facility located in State College, Pennsylvania. On July 5, 2013 and April 17, 2013, the Company sold Data Bus and Sensors and repaid approximately $28,780 and $44,919, respectively, of its term loans from the proceeds of these sales, in accordance with the Term Loan Agreement. In addition, the Company repaid a portion of its term loans using the net proceeds of $739 from the March 14, 2013, sale of certain land and a building in Palm Bay, Florida.
	On May 22, 2013, the Company entered into a First Amendment to the Revolving Loan Agreement that amends certain cash management and reporting requirements.
	On October 10, 2013, the Company entered into an Amendment No. 1 to the Credit Agreement (the “Amendment No. 1”) by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 1, among other things, amends the Term Loan Agreement to reduce the minimum interest coverage ratio, increase the maximum leverage ratio, reduce the interest rate on the term loans and modify the terms of the prepayment premium, which the Company is required to pay upon voluntary prepayments or certain mandatory prepayments of the term loans.
	On March 21, 2014, the Company entered into Amendment No. 2 to the Credit Agreement (the “Amendment No. 2”), by and among the Company, as borrower, the lenders party thereto and the Agent.
	Amendment No. 2 amends the Term Loan Agreement to provide for an incremental term loan facility in an aggregate principal amount equal to $55,000 (the “Incremental Term Loan Facility”), which Incremental Term Loan Facility is subject to substantially the same terms and conditions, including the applicable interest rate and the maturity date of February 6, 2018, as the $165,000 term loan facility provided upon the initial closing of the Term Loan Agreement. In addition, Amendment No. 2 amends the Term Loan Agreement to reduce the minimum interest coverage ratio and increase the maximum leverage ratio, among other things.
	The proceeds of the Incremental Term Loan Facility were used (i) to pay in full and terminate the Company’s Revolving Loan Agreement; (ii) to redeem all 26,000 shares of the Company’s Series A Preferred Stock that were outstanding (as defined and described in Note 10); (iii) to pay fees, costs and expenses associated with the Incremental Term Loan Facility and related transactions; and (iv) for general corporate purposes. This resulted in the write-off of approximately $10,212 of deferred financing costs and note discounts in the quarter ended May 31, 2014.
	Term Loan Agreement
	The term loans incurred pursuant to the Term Loan Agreement, as amended, bear interest, at the Company’s option, at the base rate plus 6.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 7.50% for the first year and at the base rate plus 7.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 10.75% thereafter, with a LIBOR floor of 1.50%. For purposes of the Term Loan Agreement, the “base rate” means the highest of Wells Fargo Bank, National Association’s prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%.
	Interest is due and payable in arrears monthly for term loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of term loans with interest periods greater than three months) in the case of term loans bearing interest at the adjusted LIBOR rate. Principal payments of the term loans are paid at the end of each of the Company’s fiscal quarters, commencing for the fiscal quarter ending May 31, 2013, with the balance of any outstanding term loans due and payable in full on February 6, 2018. The quarterly principal payments will amortize at 1.25% for the fiscal quarters through the end of the Company’s 2014 fiscal year, at 1.875% for the fiscal quarters through the end of the Company’s 2015 fiscal year and at 2.50% for each of the fiscal quarters thereafter.
	Under certain circumstances, the Company is required to prepay the term loans upon the receipt of cash proceeds of certain asset sales, cash proceeds of certain extraordinary receipts and cash proceeds of certain debt or equity financings, and based on a calculation of annual excess cash flow. Mandatory prepayments resulting from assets sales or certain debt financings may require the payment of certain prepayment premiums.
	The term loans are secured by a first priority security interest in accounts receivable, inventory, machinery, equipment and certain other personal property relating to the foregoing, and any proceeds from any of the foregoing, subject to certain exceptions and liens, and a first priority security position on substantially all other real and personal property, in each case that are owned by the Company and the subsidiary guarantors.
	The Term Loan Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company and its subsidiaries’ ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a term loan of this size and type.
	Pursuant to the Term Loan Agreement, the Company is required to maintain compliance with an interest coverage ratio and a leverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights).
	Revolving Loan Agreement
	On March 21, 2014, approximately $25,136 of the proceeds of the Incremental Term Loan Facility were used to pay in full and terminate the Company’s Revolving Loan Agreement.
	The revolving loans incurred pursuant to the Revolving Loan Agreement bore interest, at the Company’s option, at the base rate plus a margin between 1.50% and 2.00% or an adjusted LIBOR rate (based on one, two, three or six-month interest periods) plus a margin between 2.50% and 3.00%, in each case with such margin being determined based on the Company’s average daily excess availability under the revolving credit facility for the preceding fiscal quarter. For purposes of the Revolving Loan Agreement, the “base rate” means the highest of Wells Fargo Bank, National Association’s prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%.
	Interest was due and payable in arrears monthly for revolving loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of revolving loans bearing interest at the adjusted LIBOR rate. Principal, together with all accrued and unpaid interest, would have been due and payable on February 6, 2018. The Company was permitted to prepay the revolving loans and terminate the commitments, in whole or in part, at any time without premium or penalty. Under certain circumstances, the Company was required to prepay the revolving loans upon the receipt of cash proceeds of certain asset sales.
	All borrowings under the Revolving Loan Agreement were limited by amounts available pursuant to a borrowing base calculation, which was based on percentages of eligible accounts receivable, inventory, machinery and equipment, in each case subject to reductions for applicable reserves.
	The Revolving Loan Agreement contained customary affirmative and negative covenants, including covenants that limited or restricted the Company and its subsidiaries’ ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a credit facility of this size and type.
	Pursuant to the Revolving Loan Agreement, the Company was also required to maintain compliance with a fixed charge coverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights) at such times that it failed to maintain excess availability under the revolving credit facility above a specified level.
	b)	A subsidiary of the Company in the United Kingdom entered into a 20 year term mortgage agreement in 2007, under which interest is charged at a margin of 1.35% over Barclays Fixed Base Rate of 0.5% at February 28, 2015. The mortgage is secured by the subsidiary’s assets.
	c)	On December 31, 2013, the Company completed the Sale/Leaseback. The Company sold the facility to an unaffiliated third party for a gross purchase price of approximately $15,500 and will lease the property from the buyer for approximately $1,279 per year, subject to annual adjustments. As a result of this transaction the Company initially recorded a capital lease obligation of $5,225. The gain on the sale has been deferred and is being recognized over the 15 year lease term.

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Feb. 28, 2015
Summary of Common Stock Option Activity	The summary of the common stock options granted, cancelled, exchanged or exercised under the Plan:
		Options			Weighted
					Average
					Exercise
					Price
	Stock Options outstanding— November 30, 2013		1,848,485		$	4.98
	Less forfeited		(765,175	)	$	4.9
	Exercised		—		$	—
	Issued		245,000		$	2.23
	Stock Options outstanding—November 30, 2014		1,328,310		$	4.52
	Less forfeited		(12,683	)	$	5.26
	Exercised		—		$	—
	Issued		—		$	—
	Stock Options outstanding—February 28, 2015		1,315,627		$	4.52
	Stock Options exercisable— February 28, 2015		1,065,211		$	5.05
Restricted Stock Unit Activity	Restricted stock unit activity under the 2006 Equity Compensation Plan is presented below:
		Units			Weighted
					Average
					Grant
					Date Fair
					Value
	RSUs outstanding— November 30, 2013		81,667		$	3.72
	Issued		15,000		$	2.37
	Exercised—Stock issued		(48,333	)	$	3.72
	RSUs outstanding—November 30, 2014		48,334		$	3.3
	Issued		—		$	—
	Exercised—Stock issued		—		$	—
	RSUs outstanding— February 28, 2015		48,334		$	3.3
	RSUs exercisable— February 28, 2015		—		$	—
Restricted Stock Units and Options Activity Range of Exercise Price
		RSUs and Options Outstanding									RSUs and Options Exercisable
	Range of	Number of			Weighted		Weighted		Aggregate		Number		Weighted		Aggregate
	Exercise Price	Outstanding			Average		Average		Intrinsic		Exercisable		Average		Intrinsic
		at Feb. 28,			Exercise		Remaining		Value		at Feb. 28,		Exercise		Value
		2015			Price		Life		(in thousands)		2015		Price		(in thousands)
							(Years)
	$0.00 – $ 3.55		690,834		$	2.83		7.65	$	94		397,500	$	3.54	$	—
	$3.56 – $ 4.99		27,084		$	3.56		5.65	$	—		21,668	$	3.56	$	—
	$5.00 – $ 6.99		640,209		$	5.95		5.59	$	—		640,209	$	5.95	$	—
	$7.00 – $ 20.00		5,834		$	14.07		2.24	$	—		5,834	$	14.07	$	—
			1,363,961					6.62	$	94		1,065,211			$	—

SUPPLEMENTAL_CASH_FLOW_INFORMA1

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	3 Months Ended
	Feb. 28, 2015
Supplemental Cash Flow Information	Supplemental cash flow information:
		(in thousands)
		Three months ended
		February 28,		February 28,
		2015		2014
	Supplemental Cash Flow Information
	Cash paid for income taxes	$	220	$	244
	Cash paid for interest	$	2,792	$	1,711
	Capital lease obligation	$	—	$	5,225

EARNINGS_PER_SHARE_OF_COMMON_S1

EARNINGS PER SHARE OF COMMON STOCK (Tables)	3 Months Ended
	Feb. 28, 2015
Computation of Weighted Average Shares Outstanding	The following table sets forth the computation of weighted-average shares outstanding for calculating basic and diluted earnings per share (EPS):
			Three months ended
			February 28
			2015		2014
	Weighted average shares-basic			55,461,217		55,426,635
	Effect of dilutive securities			*		*
	Weighted average shares—diluted			55,461,217		55,426,635
	*	Outstanding options and RSUs aggregating 1,363,961 – February 28, 2015 (1,756,937 – February 28, 2014) incremental shares, and 892,862 warrants at February 28, 2014 have been excluded from the February 28, 2015 and 2014 computation of diluted EPS as they are anti-dilutive due to the losses generated in each respective period.

RESTRUCTURING_CHARGES_RELATED_1

RESTRUCTURING CHARGES RELATED TO CONSOLIDATION OF OPERATIONS (Tables)	3 Months Ended
	Feb. 28, 2015
Summary of Charges Related to EMS Restructuring Activities by Type of Cost	The following tables summarize the charges related to EMS restructuring activities by type of cost:
		EMS
		Restructuring
		(in thousands)
	Salary and related charges	$	591
	Inventory write-down		7,401
	Fixed asset impairment		865
	Lease impairment		3,672
	Accumulated restructuring charges at November 30, 2012		12,529
	Cash payments		(591	)
	Non-cash charges		(10,028	)
	Balance – Lease impairment accrual, February 28, 2015	$	1,910

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	3 Months Ended
	Feb. 28, 2015
Schedule of Segment Reporting Information, by Segment
	Three months ended February 28, 2015		SSC		SSIA		EMS		Corporate		Inter		Total
											Segment
	(in thousands)										Eliminations
	Revenue from external customers		$	38,386	$	4,258	$	8,206	$	—	$	—	$	50,850
	Adjusted EBITDA:			5,242		755		50		—		—		6,047
	Acquisition related charges													62
	Restructuring													872
	Depreciation and amortization													3,459
	Interest expense, net													3,127
	Amortization of note discounts and deferred financing costs													23
	Other adjustments *													411
	Loss before income taxes												$	(1,907	)
	Segment assets—as at February 28, 2015		$	240,496	$	11,670	$	25,187	$	1,382	$	—	$	278,735
	Goodwill included in assets—as at Feb. 28, 2015		$	114,301	$	—	$	2,469	$	—	$	—	$	116,770
	Purchase of fixed assets, to February 28, 2015		$	144	$	12	$	3	$	—	$	—	$	159
	Three months ended February 28, 2014		SSC		SSIA		EMS		Corporate		Inter		Total
											Segment
	(in thousands)										Eliminations
	Revenue from external customers		$	39,661	$	5,399	$	13,858	$	—	$	—	$	58,918
	Adjusted EBITDA:			4,390		1,081		1,023		—		—		6,494
	Acquisition related charges													110
	Restructuring													417
	Depreciation and amortization													4,130
	Interest expense, net													2,410
	Amortization of note discounts and deferred financing costs													665
	Other adjustments *													380
	Loss before income taxes												$	(1,618	)
	Segment assets—as at November 30, 2014		$	241,246	$	13,183	$	24,235	$	4,176	$	—	$	282,840
	Goodwill included in assets—as at Nov. 30, 2014		$	114,301	$	—	$	2,469	$	—	$	—	$	116,770
	Purchase of fixed assets, to February 28, 2014		$	63	$	15	$	27	$	—	$	—	$	105
	*	Other adjustments primarily include non-cash inventory provisions, stock based compensation, franchise taxes, financing and other adjustments, lease payments for the State College, Pennsylvania facility, foreign exchange losses and a change in benefit liability.

Recovered_Sheet1

Nature of Business and Basis of Presentation - Additional Information (Detail) (USD $)	0 Months Ended				3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Jul. 05, 2013	Apr. 17, 2013	Mar. 14, 2013	Feb. 28, 2015	Feb. 28, 2014
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Repayment of term loans from the proceeds of the sale	$14,200	$28,780	$44,919	$739	$2,500	$25,480
Pennsylvania
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from sale and leaseback facility	15,500
Sale and leaseback transaction annual rental payments	$1,279

Fixed_Assets_Depreciation_Peri

Fixed Assets Depreciation Period (Detail)	3 Months Ended
	Feb. 28, 2015
Minimum | Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Useful life	5 years
Minimum | Computer equipment
Property, Plant and Equipment [Line Items]
Useful life	3 years
Minimum | Furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life	5 years
Minimum | Machinery and equipment
Property, Plant and Equipment [Line Items]
Useful life	5 years
Maximum | Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Useful life	40 years
Maximum | Computer equipment
Property, Plant and Equipment [Line Items]
Useful life	5 years
Maximum | Furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life	8 years
Maximum | Machinery and equipment
Property, Plant and Equipment [Line Items]
Useful life	10 years
Maximum | Vehicles
Property, Plant and Equipment [Line Items]
Useful life	3 years

Amortization_Period_of_Finite_

Amortization Period of Finite Lived Intangible Assets (Detail)	3 Months Ended
	Feb. 28, 2015
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	5 years
Finite lived intangible assets amortization method	Straight line over 5 years
Computer Software, Intangible Asset
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets amortization method	Straight line over 3-5 years
Computer Software, Intangible Asset | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	3 years
Computer Software, Intangible Asset | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	5 years
Customer Related Intangibles
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets amortization method	Straight line or the pattern in which the economic benefits are expected to be realized, over an estimated life of 4-15 years
Customer Related Intangibles | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	4 years
Customer Related Intangibles | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	15 years
Marketing Related Intangibles
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets amortization method	The pattern in which the economic benefits are expected to be realized, over an estimated life of 3-10 years
Marketing Related Intangibles | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	3 years
Marketing Related Intangibles | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	10 years
Technology Related Intangibles
Finite-Lived Intangible Assets [Line Items]
Amortization period of finite lived intangible assets	10 years
Finite lived intangible assets amortization method	The pattern in which the economic benefits are expected to be realized, over an estimated life of 10 years

Recovered_Sheet2

Summary of Significant Accounting Policies - Additional Information (Detail)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Summary Of Significant Accounting Policies [Line Items]
Income tax position rate	50.00%
Customer Concentration Risk | Revenues | UNITED STATES
Summary Of Significant Accounting Policies [Line Items]
Concentration risk	41.00%	49.00%
Customer Concentration Risk | Revenues | CANADA
Summary Of Significant Accounting Policies [Line Items]
Concentration risk	1.00%	3.00%
Customer Concentration Risk | Revenues | UNITED KINGDOM
Summary Of Significant Accounting Policies [Line Items]
Concentration risk	11.00%	10.00%

Inventories_Detail

Inventories (Detail) (USD $)	Feb. 28, 2015	Nov. 30, 2014
In Thousands, unless otherwise specified
Inventory [Line Items]
Raw materials	$31,228	$30,509
Work in progress	17,641	16,130
Finished goods	9,362	8,079
Total	$58,231	$54,718

Inventories_Additional_Informa

Inventories - Additional Information (Detail) (USD $)	Feb. 28, 2015	Nov. 30, 2014
In Thousands, unless otherwise specified
Inventory [Line Items]
Inventory reserves	$9,159	$8,990

Short_Term_Debt_Additional_Inf

Short Term Debt - Additional Information (Detail) (UNITED KINGDOM)	Feb. 28, 2015	Feb. 28, 2015
In Thousands, unless otherwise specified	USD ($)	GBP (£)
Debt [Line Items]
Credit facility for subsidiary	$388	£ 250

Recovered_Sheet3

Accounts Payable and Accrued Expenses (Detail) (USD $)	Feb. 28, 2015	Nov. 30, 2014
In Thousands, unless otherwise specified
Accounts Payable [Line Items]
Trade accounts payable	$18,884	$16,843
Accrued expenses	6,505	6,497
Wage and vacation accrual	3,246	4,567
Total	$28,635	$27,907

LongTerm_Debt_Obligations_Deta

Long-Term Debt Obligations (Detail) (USD $)	Feb. 28, 2015		Nov. 30, 2014
In Thousands, unless otherwise specified
Debt [Line Items]
Term loans, due February 6, 2018, base rate plus 6.50% interest or LIBOR plus 7.50%,	$119,266	[1]	$121,730	[1]
Mortgage loan, due 2027, 1.35% above Barclays fixed bank rate	1,098	[2]	1,151	[2]
Capital leases payable	5,417	[3]	5,430	[3]
Total Loans	125,781		128,311
Less: Current portion of long-term debt	-10,916		-10,097
Long-term portion	$114,865		$118,214
[1]	On February 6, 2013, the Company refinanced its credit facilities and entered into (i) a credit agreement (the "Term Loan Agreement") with various lenders and Guggenheim Corporate Funding, LLC, as agent (the "Agent") that provides for a $165,000 term loan facility and (ii) a credit agreement with various lenders and Wells Fargo Bank, National Association (the "Revolving Loan Agreement") that provides for a $50,000 asset-based revolving borrowing base credit facility, with a $10,000 subfacility (or the Sterling equivalent) for certain of our United Kingdom subsidiaries, a $10,000 subfacility for letters of credit and a $5,000 subfacility for swingline loans. On February 6, 2013, in connection with entering into the Term Loan Agreement and the Revolving Loan Agreement, the Amended and Restated Credit Agreement, dated as of June 27, 2011 and amended on January 6, 2012 and March 22, 2012, by and among the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, lead arranger and sole book-runner, which had an outstanding balance of $183,400 was paid off and terminated, which resulted in the write-off of approximately $10,300 of deferred financing costs and note discounts. On December 31, 2013, the Company repaid $14,200 of its term loans from the proceeds of the Sale/Leaseback, (see (c) below) of the Company's facility located in State College, Pennsylvania. On July 5, 2013 and April 17, 2013, the Company sold Data Bus and Sensors and repaid approximately $28,780 and $44,919, respectively, of its term loans from the proceeds of these sales, in accordance with the Term Loan Agreement. In addition, the Company repaid a portion of its term loans using the net proceeds of $739 from the March 14, 2013, sale of certain land and a building in Palm Bay, Florida. On May 22, 2013, the Company entered into a First Amendment to the Revolving Loan Agreement that amends certain cash management and reporting requirements. On October 10, 2013, the Company entered into an Amendment No. 1 to the Credit Agreement (the "Amendment No. 1") by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 1, among other things, amends the Term Loan Agreement to reduce the minimum interest coverage ratio, increase the maximum leverage ratio, reduce the interest rate on the term loans and modify the terms of the prepayment premium, which the Company is required to pay upon voluntary prepayments or certain mandatory prepayments of the term loans. On March 21, 2014, the Company entered into Amendment No. 2 to the Credit Agreement (the "Amendment No. 2"), by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 2 amends the Term Loan Agreement to provide for an incremental term loan facility in an aggregate principal amount equal to $55,000 (the "Incremental Term Loan Facility"), which Incremental Term Loan Facility is subject to substantially the same terms and conditions, including the applicable interest rate and the maturity date of February 6, 2018, as the $165,000 term loan facility provided upon the initial closing of the Term Loan Agreement. In addition, Amendment No. 2 amends the Term Loan Agreement to reduce the minimum interest coverage ratio and increase the maximum leverage ratio, among other things. The proceeds of the Incremental Term Loan Facility were used (i) to pay in full and terminate the Company's Revolving Loan Agreement; (ii) to redeem all 26,000 shares of the Company's Series A Preferred Stock that were outstanding (as defined and described in Note 10); (iii) to pay fees, costs and expenses associated with the Incremental Term Loan Facility and related transactions; and (iv) for general corporate purposes. This resulted in the write-off of approximately $10,212 of deferred financing costs and note discounts in the quarter ended May 31, 2014. Term Loan Agreement The term loans incurred pursuant to the Term Loan Agreement, as amended, bear interest, at the Company's option, at the base rate plus 6.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 7.50% for the first year and at the base rate plus 7.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 10.75% thereafter, with a LIBOR floor of 1.50%. For purposes of the Term Loan Agreement, the "base rate" means the highest of Wells Fargo Bank, National Association's prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%. Interest is due and payable in arrears monthly for term loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of term loans with interest periods greater than three months) in the case of term loans bearing interest at the adjusted LIBOR rate. Principal payments of the term loans are paid at the end of each of the Company's fiscal quarters, commencing for the fiscal quarter ending May 31, 2013, with the balance of any outstanding term loans due and payable in full on February 6, 2018. The quarterly principal payments will amortize at 1.25% for the fiscal quarters through the end of the Company's 2014 fiscal year, at 1.875% for the fiscal quarters through the end of the Company's 2015 fiscal year and at 2.50% for each of the fiscal quarters thereafter. Under certain circumstances, the Company is required to prepay the term loans upon the receipt of cash proceeds of certain asset sales, cash proceeds of certain extraordinary receipts and cash proceeds of certain debt or equity financings, and based on a calculation of annual excess cash flow. Mandatory prepayments resulting from assets sales or certain debt financings may require the payment of certain prepayment premiums. The term loans are secured by a first priority security interest in accounts receivable, inventory, machinery, equipment and certain other personal property relating to the foregoing, and any proceeds from any of the foregoing, subject to certain exceptions and liens, and a first priority security position on substantially all other real and personal property, in each case that are owned by the Company and the subsidiary guarantors. The Term Loan Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company and its subsidiaries' ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a term loan of this size and type. Pursuant to the Term Loan Agreement, the Company is required to maintain compliance with an interest coverage ratio and a leverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights). Revolving Loan Agreement On March 21, 2014, approximately $25,136 of the proceeds of the Incremental Term Loan Facility were used to pay in full and terminate the Company's Revolving Loan Agreement. The revolving loans incurred pursuant to the Revolving Loan Agreement bore interest, at the Company's option, at the base rate plus a margin between 1.50% and 2.00% or an adjusted LIBOR rate (based on one, two, three or six-month interest periods) plus a margin between 2.50% and 3.00%, in each case with such margin being determined based on the Company's average daily excess availability under the revolving credit facility for the preceding fiscal quarter. For purposes of the Revolving Loan Agreement, the "base rate" means the highest of Wells Fargo Bank, National Association's prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%. Interest was due and payable in arrears monthly for revolving loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of revolving loans bearing interest at the adjusted LIBOR rate. Principal, together with all accrued and unpaid interest, would have been due and payable on February 6, 2018. The Company was permitted to prepay the revolving loans and terminate the commitments, in whole or in part, at any time without premium or penalty. Under certain circumstances, the Company was required to prepay the revolving loans upon the receipt of cash proceeds of certain asset sales. All borrowings under the Revolving Loan Agreement were limited by amounts available pursuant to a borrowing base calculation, which was based on percentages of eligible accounts receivable, inventory, machinery and equipment, in each case subject to reductions for applicable reserves. The Revolving Loan Agreement contained customary affirmative and negative covenants, including covenants that limited or restricted the Company and its subsidiaries' ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a credit facility of this size and type. Pursuant to the Revolving Loan Agreement, the Company was also required to maintain compliance with a fixed charge coverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights) at such times that it failed to maintain excess availability under the revolving credit facility above a specified level
[2]	A subsidiary of the Company in the United Kingdom entered into a 20 year term mortgage agreement in 2007, under which interest is charged at a margin of 1.35% over Barclays Fixed Base Rate of 0.5% at February 28, 2015. The mortgage is secured by the subsidiary's assets.
[3]	On December 31, 2013, the Company completed the Sale/Leaseback. The Company sold the facility to an unaffiliated third party for a gross purchase price of approximately $15,500 and will lease the property from the buyer for approximately $1,279 per year, subject to annual adjustments. As a result of this transaction the Company initially recorded a capital lease obligation of $5,225. The gain on the sale has been deferred and is being recognized over the 15 year lease term.

LongTerm_Debt_Obligations_Pare

Long-Term Debt Obligations (Parenthetical) (Detail) (USD $)

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

In Thousands, except Share data, unless otherwise specified

Dec. 31, 2013

Jul. 05, 2013

Apr. 17, 2013

Mar. 14, 2013

Feb. 28, 2015

Feb. 28, 2014

Mar. 21, 2014

31-May-14

Nov. 30, 2014

Feb. 06, 2013

Debt [Line Items]

Long Term Loans Payable

$119,266

[1]

$121,730

[1]

Outstanding loan balance, paid off and terminated

183,400

Write-off of deferred financing cost

10,300

Repayment of term loans from the proceeds of the sale

14,200

28,780

44,919

739

2,500

25,480

Capital lease obligation

5,417

[2]

5,430

[2]

UNITED KINGDOM

Debt [Line Items]

Mortgage agreement term

20 years

Mortgage loan interest charges

1.35%

Barclays | UNITED KINGDOM

Debt [Line Items]

Barclays Fixed Base Rate

0.50%

Term Loan A

Debt [Line Items]

Long Term Loans Payable

165,000

Debt instrument maturity date

6-Feb-18

Federal funds rate

0.50%

Term loan, principal payment commencement date

31-May-13

Term loan, amortization percentage for principal payments, 2014 fiscal year

1.25%

Term loan, amortization percentage for principal payments, 2015 fiscal year

1.88%

Term loan, amortization percentage for principal payments, thereafter

2.50%

Term loan, annual capital expenditure

4,000

Term loan, proceeds

25,136

Term Loan A | Three Month Libor Rate Plus

Debt [Line Items]

LIBOR

1.00%

Term Loan A | Base Rate | 2014

Debt [Line Items]

Debt instrument, margin plus rate

6.50%

Term Loan A | Base Rate | Thereafter

Debt [Line Items]

Debt instrument, margin plus rate

7.50%

Term Loan A | London Interbank Offered Rate (LIBOR) | 2014

Debt [Line Items]

Debt instrument, margin plus rate

7.50%

Term Loan A | London Interbank Offered Rate (LIBOR) | Thereafter

Debt [Line Items]

Debt instrument, margin plus rate

10.75%

Incremental Term Loan Facility

Debt [Line Items]

Long Term Loans Payable

55,000

Debt instrument maturity date

6-Feb-18

Term Loan B

Debt [Line Items]

Term loan, annual capital expenditure

4,000

Asset Based Revolving Credit Facility

Debt [Line Items]

Secured revolving credit facility

50,000

Credit Sub Facility

Debt [Line Items]

Secured revolving credit facility

10,000

Letter Of Credit Sub Facility

Debt [Line Items]

Secured revolving credit facility

10,000

Swing Line Loan Subfacility

Debt [Line Items]

Secured revolving credit facility

5,000

Series A Preferred Stock

Debt [Line Items]

Write-off of deferred financing cost

10,212

Series A Mandatorily Redeemable Preferred Stock redeemed, shares

26,000

26,000

Revolving Loan Agreement

Debt [Line Items]

Federal funds rate

0.50%

Revolving Loan Agreement | Three Month Libor Rate Plus

Debt [Line Items]

LIBOR

1.00%

Pennsylvania

Debt [Line Items]

Proceeds from sale and leaseback facility

15,500

Sale and leaseback transaction annual rental payments

1,279

Capital lease obligation

$5,225

Lease term

15 years

Maximum | Term Loan A

Debt [Line Items]

LIBOR

1.50%

Maximum | Revolving Loan Agreement | Base Rate

Debt [Line Items]

Debt instrument, margin plus rate

2.00%

Maximum | Revolving Loan Agreement | London Interbank Offered Rate (LIBOR)

Debt [Line Items]

Debt instrument, margin plus rate

3.00%

Minimum | Revolving Loan Agreement | Base Rate

Debt [Line Items]

Debt instrument, margin plus rate

1.50%

Minimum | Revolving Loan Agreement | London Interbank Offered Rate (LIBOR)

Debt [Line Items]

Debt instrument, margin plus rate

2.50%

[1]

On February 6, 2013, the Company refinanced its credit facilities and entered into (i) a credit agreement (the "Term Loan Agreement") with various lenders and Guggenheim Corporate Funding, LLC, as agent (the "Agent") that provides for a $165,000 term loan facility and (ii) a credit agreement with various lenders and Wells Fargo Bank, National Association (the "Revolving Loan Agreement") that provides for a $50,000 asset-based revolving borrowing base credit facility, with a $10,000 subfacility (or the Sterling equivalent) for certain of our United Kingdom subsidiaries, a $10,000 subfacility for letters of credit and a $5,000 subfacility for swingline loans. On February 6, 2013, in connection with entering into the Term Loan Agreement and the Revolving Loan Agreement, the Amended and Restated Credit Agreement, dated as of June 27, 2011 and amended on January 6, 2012 and March 22, 2012, by and among the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, lead arranger and sole book-runner, which had an outstanding balance of $183,400 was paid off and terminated, which resulted in the write-off of approximately $10,300 of deferred financing costs and note discounts. On December 31, 2013, the Company repaid $14,200 of its term loans from the proceeds of the Sale/Leaseback, (see (c) below) of the Company's facility located in State College, Pennsylvania. On July 5, 2013 and April 17, 2013, the Company sold Data Bus and Sensors and repaid approximately $28,780 and $44,919, respectively, of its term loans from the proceeds of these sales, in accordance with the Term Loan Agreement. In addition, the Company repaid a portion of its term loans using the net proceeds of $739 from the March 14, 2013, sale of certain land and a building in Palm Bay, Florida. On May 22, 2013, the Company entered into a First Amendment to the Revolving Loan Agreement that amends certain cash management and reporting requirements. On October 10, 2013, the Company entered into an Amendment No. 1 to the Credit Agreement (the "Amendment No. 1") by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 1, among other things, amends the Term Loan Agreement to reduce the minimum interest coverage ratio, increase the maximum leverage ratio, reduce the interest rate on the term loans and modify the terms of the prepayment premium, which the Company is required to pay upon voluntary prepayments or certain mandatory prepayments of the term loans. On March 21, 2014, the Company entered into Amendment No. 2 to the Credit Agreement (the "Amendment No. 2"), by and among the Company, as borrower, the lenders party thereto and the Agent. Amendment No. 2 amends the Term Loan Agreement to provide for an incremental term loan facility in an aggregate principal amount equal to $55,000 (the "Incremental Term Loan Facility"), which Incremental Term Loan Facility is subject to substantially the same terms and conditions, including the applicable interest rate and the maturity date of February 6, 2018, as the $165,000 term loan facility provided upon the initial closing of the Term Loan Agreement. In addition, Amendment No. 2 amends the Term Loan Agreement to reduce the minimum interest coverage ratio and increase the maximum leverage ratio, among other things. The proceeds of the Incremental Term Loan Facility were used (i) to pay in full and terminate the Company's Revolving Loan Agreement; (ii) to redeem all 26,000 shares of the Company's Series A Preferred Stock that were outstanding (as defined and described in Note 10); (iii) to pay fees, costs and expenses associated with the Incremental Term Loan Facility and related transactions; and (iv) for general corporate purposes. This resulted in the write-off of approximately $10,212 of deferred financing costs and note discounts in the quarter ended May 31, 2014. Term Loan Agreement The term loans incurred pursuant to the Term Loan Agreement, as amended, bear interest, at the Company's option, at the base rate plus 6.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 7.50% for the first year and at the base rate plus 7.50% or an adjusted LIBOR rate (based on one, two or three-month interest periods) plus 10.75% thereafter, with a LIBOR floor of 1.50%. For purposes of the Term Loan Agreement, the "base rate" means the highest of Wells Fargo Bank, National Association's prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%. Interest is due and payable in arrears monthly for term loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of term loans with interest periods greater than three months) in the case of term loans bearing interest at the adjusted LIBOR rate. Principal payments of the term loans are paid at the end of each of the Company's fiscal quarters, commencing for the fiscal quarter ending May 31, 2013, with the balance of any outstanding term loans due and payable in full on February 6, 2018. The quarterly principal payments will amortize at 1.25% for the fiscal quarters through the end of the Company's 2014 fiscal year, at 1.875% for the fiscal quarters through the end of the Company's 2015 fiscal year and at 2.50% for each of the fiscal quarters thereafter. Under certain circumstances, the Company is required to prepay the term loans upon the receipt of cash proceeds of certain asset sales, cash proceeds of certain extraordinary receipts and cash proceeds of certain debt or equity financings, and based on a calculation of annual excess cash flow. Mandatory prepayments resulting from assets sales or certain debt financings may require the payment of certain prepayment premiums. The term loans are secured by a first priority security interest in accounts receivable, inventory, machinery, equipment and certain other personal property relating to the foregoing, and any proceeds from any of the foregoing, subject to certain exceptions and liens, and a first priority security position on substantially all other real and personal property, in each case that are owned by the Company and the subsidiary guarantors. The Term Loan Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company and its subsidiaries' ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a term loan of this size and type. Pursuant to the Term Loan Agreement, the Company is required to maintain compliance with an interest coverage ratio and a leverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights). Revolving Loan Agreement On March 21, 2014, approximately $25,136 of the proceeds of the Incremental Term Loan Facility were used to pay in full and terminate the Company's Revolving Loan Agreement. The revolving loans incurred pursuant to the Revolving Loan Agreement bore interest, at the Company's option, at the base rate plus a margin between 1.50% and 2.00% or an adjusted LIBOR rate (based on one, two, three or six-month interest periods) plus a margin between 2.50% and 3.00%, in each case with such margin being determined based on the Company's average daily excess availability under the revolving credit facility for the preceding fiscal quarter. For purposes of the Revolving Loan Agreement, the "base rate" means the highest of Wells Fargo Bank, National Association's prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted LIBOR rate for a 3-month interest period plus a margin equal to 1.00%. Interest was due and payable in arrears monthly for revolving loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of revolving loans bearing interest at the adjusted LIBOR rate. Principal, together with all accrued and unpaid interest, would have been due and payable on February 6, 2018. The Company was permitted to prepay the revolving loans and terminate the commitments, in whole or in part, at any time without premium or penalty. Under certain circumstances, the Company was required to prepay the revolving loans upon the receipt of cash proceeds of certain asset sales. All borrowings under the Revolving Loan Agreement were limited by amounts available pursuant to a borrowing base calculation, which was based on percentages of eligible accounts receivable, inventory, machinery and equipment, in each case subject to reductions for applicable reserves. The Revolving Loan Agreement contained customary affirmative and negative covenants, including covenants that limited or restricted the Company and its subsidiaries' ability to, among other things, incur indebtedness, grant liens, dispose of assets and pay dividends or make distributions to stockholders, in each case subject to customary exceptions for a credit facility of this size and type. Pursuant to the Revolving Loan Agreement, the Company was also required to maintain compliance with a fixed charge coverage ratio and to limit its annual capital expenditures to $4,000 per fiscal year (subject to carry-over rights) at such times that it failed to maintain excess availability under the revolving credit facility above a specified level

[2]

On December 31, 2013, the Company completed the Sale/Leaseback. The Company sold the facility to an unaffiliated third party for a gross purchase price of approximately $15,500 and will lease the property from the buyer for approximately $1,279 per year, subject to annual adjustments. As a result of this transaction the Company initially recorded a capital lease obligation of $5,225. The gain on the sale has been deferred and is being recognized over the 15 year lease term.

Shareholders_Equity_Additional

Shareholders' Equity - Additional Information (Detail) (USD $)	3 Months Ended		0 Months Ended	3 Months Ended	0 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Mar. 21, 2014	31-May-14	Jan. 20, 2010	Jan. 22, 2010	Nov. 30, 2014	Nov. 06, 2006
Equity [Line Items]
Common shares, shares authorized	250,000,000						250,000,000
Common shares, shares outstanding	55,397,320						55,397,320
Stock issued, options and RSUs	0	0
Series A Preferred Stock
Equity [Line Items]
Series A Mandatorily Redeemable Preferred Stock redeemed, shares			26,000	26,000
API
Equity [Line Items]
Common shares, shares outstanding	63,886
Exchangeable share outstanding	22,617
API | Exchangeable Shares
Equity [Line Items]
Common shares, shares authorized								2,354,505
Equity Based Compensation
Equity [Line Items]
Share authorized					800,000
Shares available for issuance					550,000
Common stock issued					250,000
Common shares issued in escrow					126,250
Common Stock | Equity Based Compensation
Equity [Line Items]
Warrants issued, shares of common stock to purchase by warrant					892,862	892,862
Warrants issued, exercise price					5.6	$5.60
Warrants expiry date					20-Jan-15	22-Jan-15
First Anniversary | Equity Based Compensation
Equity [Line Items]
Shares available for issuance					250,000
Second Anniversary | Equity Based Compensation
Equity [Line Items]
Shares available for issuance					300,000

StockBased_Compensation_Additi

Stock-Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014	Jan. 21, 2011
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Equity incentive plan under common stock			5,875,000
Available for issuance pursuant to option, RSUs, or Stock	3,752,072
Maximum award term	10 years
Stock option exercise price	100.00%
Total unrecognized compensation related non-vested stock options	$197
Stock based compensation	$79	($48)
Market value per share	$1.94

Summary_of_Common_Stock_Option

Summary of Common Stock Option Activity (Detail) (USD $)	3 Months Ended	12 Months Ended
	Feb. 28, 2015	Nov. 30, 2014
Options
Beginning Balance	1,328,310	1,848,485
Less forfeited	-12,683	-765,175
Exercised	0	0
Issued		245,000
Ending Balance	1,315,627	1,328,310
Stock Options exercisable	1,065,211
Weighted Average Exercise Price
Beginning Balance	$4.52	$4.98
Less forfeited	$5.26	$4.90
Weighted Average Exercise Price, Exercised	$0	$0
Weighted Average Exercise Price, Issued		$2.23
Ending Balance	$4.52	$4.52
Stock Options exercisable	$5.05

Restricted_Stock_Unit_Activity

Restricted Stock Unit Activity (Detail) (Restricted Stock Units (RSUs), USD $)	12 Months Ended
	Nov. 30, 2014	Feb. 28, 2015
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs Outstanding, Beginning Balance	81,667	48,334
Issued	15,000
Exercised-Stock issued	-48,333
RSUs Outstanding , Ending Balance	48,334	48,334
Exercisable		0
Weighted Average Grant Date Fair Value, Beginning Balance	$3.72	$3.30
Issued	$2.37
Exercised-Stock issued	$3.72
Weighted Average Grant Date Fair Value, Ending Balance	$3.30	$3.30
Exercisable		$0

Restricted_Stock_Unit_Activity1

Restricted Stock Unit Activity Range of Exercise Price (Detail) (RSUs and Options, USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 28, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Outstanding Shares	1,363,961
Options Outstanding, Weighted Average Remaining Life (Years)	6 years 7 months 13 days
Options Outstanding, Aggregate Intrinsic Value	$94
Options Exercisable, Number Exercisable Shares	1,065,211
Options Exercisable, Aggregate Intrinsic Value	0
$0.00 - $ 3.55
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Range Limit	$0
Exercise Price, Upper Range Limit	$3.55
Options Outstanding, Number of Outstanding Shares	690,834
Options Outstanding, Weighted Average Exercise Price	$2.83
Options Outstanding, Weighted Average Remaining Life (Years)	7 years 7 months 24 days
Options Outstanding, Aggregate Intrinsic Value	94
Options Exercisable, Number Exercisable Shares	397,500
Options Exercisable, Weighted Average Exercise Price	$3.54
Options Exercisable, Aggregate Intrinsic Value	0
$3.56 - $ 4.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Range Limit	$3.56
Exercise Price, Upper Range Limit	$4.99
Options Outstanding, Number of Outstanding Shares	27,084
Options Outstanding, Weighted Average Exercise Price	$3.56
Options Outstanding, Weighted Average Remaining Life (Years)	5 years 7 months 24 days
Options Exercisable, Number Exercisable Shares	21,668
Options Exercisable, Weighted Average Exercise Price	$3.56
Options Exercisable, Aggregate Intrinsic Value	0
$5.00 - $ 6.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Range Limit	$5
Exercise Price, Upper Range Limit	$6.99
Options Outstanding, Number of Outstanding Shares	640,209
Options Outstanding, Weighted Average Exercise Price	$5.95
Options Outstanding, Weighted Average Remaining Life (Years)	5 years 7 months 2 days
Options Exercisable, Number Exercisable Shares	640,209
Options Exercisable, Weighted Average Exercise Price	$5.95
Options Exercisable, Aggregate Intrinsic Value	0
$7.00 - $ 20.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Range Limit	$7
Exercise Price, Upper Range Limit	$20
Options Outstanding, Number of Outstanding Shares	5,834
Options Outstanding, Weighted Average Exercise Price	$14.07
Options Outstanding, Weighted Average Remaining Life (Years)	2 years 2 months 27 days
Options Exercisable, Number Exercisable Shares	5,834
Options Exercisable, Weighted Average Exercise Price	$14.07
Options Exercisable, Aggregate Intrinsic Value	$0

Recovered_Sheet4

Supplemental Cash Flow Information (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014
Supplemental Cash Flow Information
Cash paid for income taxes	$220	$244
Cash paid for interest	2,792	1,711
Capital lease obligation		$5,225

Recovered_Sheet5

Supplemental Cash Flow Information - Additional Information (Detail) (USD $)	1 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2014
Supplemental Cash Flow Information [Line Items]
Tax refund	$1,414

Earnings_Per_Share_Table_Detai

Earnings Per Share Table (Detail)	3 Months Ended
	Feb. 28, 2015		Feb. 28, 2014
Earnings Per Share [Line Items]
Weighted average shares-basic	55,461,217		55,426,635
Effect of dilutive securities		[1]		[1]
Weighted average shares-diluted	55,461,217		55,426,635
[1]	Outstanding options and RSUs aggregating 1,363,961 - February 28, 2015 (1,756,937 - February 28, 2014) incremental shares, and 892,862 warrants at February 28, 2014 have been excluded from the February 28, 2015 and 2014 computation of diluted EPS as they are anti-dilutive due to the losses generated in each respective period.

Earnings_Per_Share_Table_Paren

Earnings Per Share Table (Parenthetical) (Detail)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Options and RSUs
Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	1,363,961	1,756,937
Warrants
Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	892,862	892,862

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)	0 Months Ended
	Jan. 20, 2010	Feb. 28, 2015	Nov. 30, 2014
Long-term Purchase Commitment [Line Items]
Common shares subscribed but not issued	423,750
Common shares subscribed but not issued value	2,373,000	$2,373,000	$2,373,000
Accrual for outstanding legal matters		$0	$0
Equity Based Compensation
Long-term Purchase Commitment [Line Items]
Shares available for issuance	550,000
Common shares issued in escrow	126,250

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Income Taxes [Line Items]
Effective income tax rates	-14.20%	-31.30%
U.S. federal statutory income tax rate	34.00%	34.00%
Unrecognized tax benefits	$0
UNITED STATES | Minimum
Income Taxes [Line Items]
Tax years open to examination	2011
UNITED STATES | Maximum
Income Taxes [Line Items]
Tax years open to examination	2014
CANADA | Minimum
Income Taxes [Line Items]
Tax years open to examination	2011
CANADA | Maximum
Income Taxes [Line Items]
Tax years open to examination	2014

Recovered_Sheet6

Restructuring Charges Related to Consolidation of Operations - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014	Nov. 30, 2012	Nov. 30, 2014	Nov. 30, 2013
Restructuring Cost and Reserve [Line Items]
Employee reduction			2.00%		3.00%
Restructuring charges	$830	$118
Restructuring	872	417
EMS Restructuring
Restructuring Cost and Reserve [Line Items]
Employee reduction			10.00%
Restructuring charges			591
Restructuring accrual	1,910
Ottawa Restructuring
Restructuring Cost and Reserve [Line Items]
Employee reduction					4.00%
Restructuring charges				2,047	2,047
Ottawa Restructuring | Accounts Payable and Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring accrual	112
Specific Restructuring Events
Restructuring Cost and Reserve [Line Items]
Restructuring	326
Recruiting Costs
Restructuring Cost and Reserve [Line Items]
Restructuring	$546

Recovered_Sheet7

Restructuring Charges Related to Consolidation of Operations (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2015	Feb. 28, 2014	Nov. 30, 2012
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$830	$118
EMS Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges			591
Inventory write-down			7,401
Fixed asset impairment			865
Lease impairment			3,672
Accumulated restructuring charges			12,529
Cash payments	-591
Non-cash charges	-10,028
Balance - Lease impairment accrual	$1,910

Segment_Information_Additional

Segment Information - Additional Information (Detail)	12 Months Ended
	Feb. 28, 2015
	Segment
Number of operating segments	3

Segment_Reporting_Information_

Segment Reporting Information by Segment (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2015		Feb. 28, 2014		Nov. 30, 2014
Operating Statistics [Line Items ]
Revenue from external customers	$50,850		$58,918
Adjusted EBITDA:	6,047		6,494
Acquisition related charges	62		110
Restructuring	872		417
Depreciation and amortization	3,459		4,130
Interest expense, net	3,127		2,410
Amortization of note discounts and deferred financing costs	23		665
Other adjustments	411	[1]	380	[1]
Loss before income taxes	-1,907		-1,618
Segment assets	278,735		282,840		282,840
Goodwill included in assets	116,770		116,770		116,770
Purchase of fixed assets	159		105
Operating Segments | Systems, Subsystems And Components
Operating Statistics [Line Items ]
Revenue from external customers	38,386		39,661
Adjusted EBITDA:	5,242		4,390
Segment assets	240,496		241,246
Goodwill included in assets	114,301		114,301
Purchase of fixed assets	144		63
Operating Segments | Secure Systems And Information Assurance
Operating Statistics [Line Items ]
Revenue from external customers	4,258		5,399
Adjusted EBITDA:	755		1,081
Segment assets	11,670		13,183
Purchase of fixed assets	12		15
Operating Segments | Electronic Manufacturing Services
Operating Statistics [Line Items ]
Revenue from external customers	8,206		13,858
Adjusted EBITDA:	50		1,023
Segment assets	25,187		24,235
Goodwill included in assets	2,469		2,469
Purchase of fixed assets	3		27
Corporate
Operating Statistics [Line Items ]
Segment assets	$1,382		$4,176
[1]	Other adjustments primarily include non-cash inventory provisions, stock based compensation, franchise taxes, financing and other adjustments, lease payments for the State College, Pennsylvania facility, foreign exchange losses and a change in benefit liability.